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ABSTRACT OF THESIS

BINDING, PROTECTION, AND RNA DELIVERY PROPERTIES OF POROUS
SILICA NANOPARTICLES IN SPODOPTERA FRUGIPERDA CELLS
Traditional methods of pest control are threatened by the development of insecticide
resistance, both to traditional insecticides and Bt toxins. Discovery of RNA interference (RNAi)
has created opportunities to develop new insect control mechanisms. However, RNAi responses
appear to be robust in coleopteran pests, but other orders, e.g. Lepidoptera and Hemiptera, present
varied or ineffective RNAi responses. Current delivery strategies for double-stranded RNA
(dsRNA) include microinjection, ingestion, and soaking. These approaches have benefits and
problems. This study investigates the potential for porous silica nanoparticles (pSNPs) to
improve the delivery of dsRNA and induce an RNAi response in Spodoptera frugiperda cells.
Initially, the binding conditions of RNA onto porous and nonporous silica nanoparticles was
examined, and the movement of RNA on and within pSNPs was observed. That information was
then applied to in vitro studies for examining the capacity of silica nanoparticles to protect
dsRNA from degradation by nucleases. This work culminated in an in vivo assay for measuring
apoptosis when dsRNA is delivered to insect cells by pSNPs. Results of these studies show that
silica nanoparticles bind nucleic acids and that dsRNA is mobile, pSNPs protect dsRNA from
nuclease degradation, and pSNP/dsRNA complexes can induce apoptosis in lepidopteran insect
cells.
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Chapter One: Literature Review
Current Problems with Pest Control
Insecticide resistance is a significant challenge for modern agriculture.
Insecticide resistance has been documented in 602 arthropod species in 21 orders to date
(Arthropod Pesticide Resistance Database, 2017). As insects become resistant to
conventional insecticides, their ranges expand. An example of these problems occurred
with the pest Helicoverpa armigera when it was documented for the first time in
Brazilian cotton and soybean fields in 2013 (Czepak et al. 2013). One strategy developed
to combat insecticide resistance was the expression of Bacillus thuringiensis delta
endotoxins in plants (Baum et al. 2007). Control of major lepidopteran and coleopteran
crop pests now rely on this technology but it is limited to a small number of crops (Lim et
al. 2015). The need for an alternative pest control strategy that is safe, easy to produce,
and insect specific is immense. RNA interference may offer new avenues for pest control
that include avoiding the cost of developing new insecticide formulations and insecticide
targets, it does not involve broad spectrum insecticides, and it may help to overcome the
problem of insects becoming resistant to transgenic plants (Gatehouse and Price 2011).
RNA Interference
All eukaryotic cells possess the ability to silence sequence-specific gene
fragments when they encounter double-stranded RNA (dsRNA) (Baum et al. 2007).
These mechanisms, referred to as RNA interference (RNAi), can silence genes essential
for processes like feeding or nutrient assimilation, and detoxification of pesticides and
Bacillus thuringiensis insecticidal proteins. RNAi targeted at these critical genes can
result in increased mortality (Baum et al. 2007). RNAi machinery is activated in cells
when foreign dsRNAs are identified and spliced into approximately 20-23 base pair (bp)
1

double-stranded nucleotide strands, called small interfering RNAs (siRNAs), by the
ribonuclease DICER (Bernstein et al. 2001). One strand of the siRNA is degraded, and
the other (called the guide RNA) is loaded into the RNA-induced silencing complex
(RISC) (Hammond et al. 2001). The guide strand recognizes complementary cellular
mRNAs (Hammond et al. 2001), and once a cellular mRNA is recognized as
complementary to the guide strand, RISC cleaves the mRNA, leading to degradation of
the mRNA so that it is no longer functional (Tomari and Zamore, 2005).
RNAi Response
There are three types of RNAi response that are relevant for insect control
applications. First is cell-autonomous RNAi, where RNA silencing is restricted to the
cell where dsRNA is injected or naturally expressed (Whangbo and Hunter, 2008). The
second is environmental RNAi, where dsRNA is taken up from the lumen by midgut cells
and induces an RNAi signal that is then replicated in cells beyond the body cavity
(Whangbo and Hunter, 2008). Lastly is systemic RNAi, which occurs when RNA and
RNAi signals are amplified and then spread from a cell where dsRNA is originally
produced or from a cell that is exposed to dsRNA (Whangbo and Hunter, 2008). This
last type of response, which has the most severe organism-wide effects, is the most
promising for insect control applications.
RNA Delivery
One challenge to developing RNAi as an insect control method is devising a
reliable way to induce dsRNA uptake into cells. The methods for dsRNA uptake in
invertebrates have been characterized through studies in Caenorhabditis elegans and
Drosophila melanogaster S2 cells (Lim et al. 2015). The first mechanism is the Systemic
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RNAi defective (SID-1 and SID-2) transmembrane proteins system (Lim et al. 2015).
There are three hypotheses for how this system works. The first states that upon
recognizing dsRNA present in the lumen, SID-2 modifies SID-1 into a channel for the
dsRNA (Whangbo and Hunter, 2008). Another hypothesis is that SID-2 may also act as a
receptor for the dsRNA in the lumen (Whangbo and Hunter, 2008). The third hypothesis
is the receptor-mediated endocytosis mechanism. It states that once SID-2 binds to the
dsRNA, a vacuole forms around the SID-2/dsRNA complex and SID-1, and then the
vacuole is pulled inside the cell (Whangbo and Hunter, 2008). Once inside the cell, SID1 acts as a channel to release the dsRNA into the cytoplasm (Whangbo and Hunter,
2008). The SID-1 channel was first recognized in C. elegans as a requirement for the
import of RNAi silencing signals (Winston et al. 2002) and was then placed in
Drosophila S2 cells to show that it had the same function in insect cells (Shih and
Hunter, 2011). It is widely recognized in the literature that there is a second mechanism
for the cellular uptake of dsRNA, but the identity of this second mechanism is debated
(Hinas et al. 2012; Shih and Hunter, 2011; Lim et al. 2015). Some researchers favor
evidence for the SID-5 model, an endosomal protein identified in C. elegans (Hinas et al.
2012), and others support the idea that SID-1 is its own mechanism and that SID-1 and
SID-2 working together is the second mechanism (Whangbo and Hunter, 2008 and
Winston et al. 2002, 2007).
Although DICER is conserved among all insects, the response to RNAi is highly
variable between insect orders (Lim et al. 2015). Certain orders, specifically
coleopterans, show much more substantial RNAi responses than others such as
Lepidoptera (Bellés, 2010). These differences in RNAi response have been explained by
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the presence or absence of dsRNA cellular import and export mechanisms, the absence of
RNAi signal amplification, and nuclease activity in cells that degrades dsRNA (Bellés,
2010; Gatehouse and Price, 2011; Gu and Knipple, 2013; Terenius et al. 2011). This
disparity in RNAi effectiveness is a major hurdle to the use of the technology for control
of lepidopteran pests.
One major challenge in the development of more effective RNAi technology is
the reliable delivery of dsRNA into cells. The strategies to deliver dsRNA to cells and
insects include microinjection, ingestion, and soaking (Yu et al. 2013). These strategies
are effective in some insects but have distinct limitations. The major advantage of
microinjection is that dsRNA is immediately delivered to the specific tissue or the
hemolymph, and other barriers such as the integument are bypassed. Also, the exact
amount of dsRNA delivered is known, which is difficult to determine with the other
methods. However, there are some distinct disadvantages to microinjection.
Specifically, microinjection is technically difficult, expensive, and time consuming.
Ingestion of dsRNA can be done in two ways: either supplying a liquid diet saturated
with dsRNA or feeding insects bacteria that express dsRNA (Yu et al. 2013). Ingestion
studies have been conducted in numerous insects, including species from the orders
Lepidoptera, Coleoptera, Ixodida, Isoptera, Hemiptera, and Diptera (Yu et al. 2013). The
advantages to oral ingestion include ease of production and performance (Tian et al.
2009), ease of high-throughput screening applications (Kamath et al. 2000), and it is less
invasive and more practical than injection, especially for smaller insects (Araujo et al.
2006; Tian et al. 2009; Walshe et al. 2009). Disadvantages include evidence that it is
not suitable for all insects, as discussed by Araujo et al. 2006 and Rajagopal et al. 2002,
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for various reasons. Soaking is most often done for cell lines (Yu et al. 2013). This
method is advantageous because it is convenient and easy to perform, facilitating highthroughput screening (Yu et al. 2013 and Wang et al. 2011). It is unclear, however, how
soaking methods translate to the organismal scale due to the added challenge of
penetrating the cuticle during application (Yu et al. 2013). The limitations of current
dsRNA delivery methods motivate the search for new and more effective strategies.
Alternative Delivery Strategies
Aside from these three main methods, there are other approaches that are less
common. These include electroporation (Karim et al. 2010), liposome encapsulation
(Whyard et al. 2009), incorporation of dsRNA into plant tissues (Zhang et al. 2013), and
nanoparticle delivery systems (He et al. 2013 and Zhang et al. 2010). Nanoparticle is a
general sized based descriptor of particles having diameters between 10 nm and 1000 nm,
but there is immense variety in nanoparticle composition. To date, there have been four
studies that used a nanoparticle to overcome challenges for the delivery of dsRNA to
whole insects (Das et al. 2015).
Using Nanoparticles in Insects for RNAi
Zhang et al. (2010) utilized chitosan nanoparticles bound to two chitin synthase
genes to increase insecticide sensitivity in Anopheles gambiae. Their goal was to analyze
the ability of nanoparticles to efficiently deliver siRNA to aquatic larvae, which is a
system currently lacking an appropriate dsRNA delivery system. Chitosan nanoparticles
were commonly used for therapeutic plasmid delivery (Howard et al. 2006 and Zhang et
al. 2010). These particles are used as self-assembling nanoparticles that do not require
finely-tuned engineering. The study of Zhang et al. (2010) also lacked any in vitro
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investigation into how the dsRNAs interacted with the chitosan-based nanoparticles or
whether the nanoparticles protected the dsRNA from environmental factors such as gut
pH and nuclease activity. Although this system increased insecticide sensitivity, the lack
of in vitro information was one of the gaps that we sought to address in our study and
design of a nanoparticle delivery system.
He et al. (2013) also used nanoparticles as a tool for enhancing RNAi in insects.
These researchers recognized that nanoparticle physicochemical properties can be
precisely controlled and fine-tuned to produce low cytotoxicity responses while also
ensuring high transfection efficiency. They used a diet that contained cationic core-shell
fluorescent nanoparticles (FNPs) bound to the dsRNA to cause knockdown of the
chitinase-like gene CHT10 in the Asian corn borer, Ostrinia furnacalis. They performed
no initial in vitro studies to explore how FNPs interacted with and protected dsRNA
before studying in vivo applications, although they found that chitinase-like dsRNA/FNP
complexes fed to larvae increased larval mortality. One extremely important observation
they made is that they determined that FNPs can pass through the peritrophic membrane,
as fluorescent particles were observed inside gut cells. They also observed accelerated
endocytosis in gut cells that had taken up the dsDNA/FNP complexes, which did not
occur with DNA, and found that FNPs are likely excreted by exocytosis, thereby
avoiding cytotoxicity. But like Zhang et al. (2010), no in vitro studies were done before
in vivo applications.
The third paper compared the use of chitosan nanoparticles, carbon quantum dots,
and the first use of silica nanoparticles, for dsRNA delivery to insects (Das et al. 2015).
This study quantified RNA binding ability of the three types of particles and discovered
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that amine functionalization is a requirement for RNA binding to silica nanoparticles, a
result which was later validated by Möller et al. (2016). This observation was the major
in vitro study before the RNA/particle complexes were fed to Aedes aegypti larvae. After
feeding amine functionalized nanoparticles loaded with the dsRNA of SNF7 and SRC to
Ae. aegypti larvae, they found no mRNA knockdown or increased larval mortality. The
study concluded that the other two delivery vehicles, carbon quantum dots and selfassembling chitosan/dsRNA complexes, were superior dsRNA delivery vehicles in
insects. However, the silica nanoparticles Das et al. (2015) used were purchased and they
did not control their engineering. The purchasing of generic nanoparticles may be
problematic as it does not control or characterize the physicochemical properties of
nanoparticles, or allow modification of these properties accordingly. To make silica
nanoparticles efficient nucleic acid carriers some degree of malleability may be required.
The final paper that investigated a nanoparticle delivery system was Thairu et al.
(2017). To overcome traditional siRNA delivery methods in nonmodel insects for the
study of gene function, they used aerosolized siRNA/nanoparticle complexes to deliver
siRNA to three species of aphids. They then compared the fate of dsRNA alone after
microinjection and dsRNA aerosolized to nanoparticles delivered through the tracheoles.
The conclusion of this paper was that the aerosolized siRNA/nanoparticle complexes can
protect siRNA from degradation but only produced an RNAi response in one of the three
species tested. This paper reinforces our belief that nanoparticles can be an effective
dsRNA delivery system, capable of producing an RNAi response, under the appropriate
conditions, which specifically includes the appropriate gene target, the siRNA amount,
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and route of delivery. However, controlling these conditions to optimize RNA delivery
and develop a viable RNAi insect control technique may be required in lepidopterans.
In contrast to entomological studies, an extensive amount of work has been done
in other systems over the past decade to characterize the interactions between
nanoparticles and biological molecules because nanoparticles have been recognized as an
important delivery mechanism (Möller et al. 2016). Initially, mesoporous silica
nanoparticles were investigated as a chemotherapy drug delivery system (Slowing et al.
2008). The need for target specific chemotherapies was a driving force in the
development of mesoporous silica nanoparticles (MSN) to meet the following criteria:
biocompatibility with target cells, large loading capacity of molecules, complete
encapsulation of molecules that ensured no early release, and a controlled release once
the MSNs entered target cells (Slowing et al. 2008). Other delivery vehicles have been
investigated, such as polymeric nanoparticles, dendrimers, and liposomes, but these
vehicles had a “leaking” problem, wherein the molecule being delivered left the vehicle
prematurely and was degraded. Silica was investigated as a molecular delivery system
because of its stability, the ease of modifying its physicochemical properties, it’s
biocompatible with cells, and the large surface area provided by pores for nucleic acid
binding and protection of nucleic acids from the environment. As the benefits of MSNs
were realized, it became necessary to optimize surface chemistry, produce uniform
internal pores, and understand how different molecules interact with the MSNs.
Researchers found that the silica surface can be amine functionalized, which adds
a positive charge to the particle. Internal particle surfaces, within the pores, can be
functionalized with basic, acidic, or hydrophobic residues to support binding with the
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payload molecules (Möller et al. 2016). For siRNA delivery, the porous MSNs (pSNP)
must be positively charged to bind to the negatively charged siRNA molecules and to cell
membranes to enable their entrance into cells and stabilize the siRNA in environments
where siRNA may be degraded (Möller et al. 2016). The pSNPs can be positively
charged by condensing positively charged aminosilanes onto the surface of the particle
(Xiong and Qiao 2016 and Lin et al. 2013). Other positively charged molecules that can
be used include metal ions, cationic polymers, and peptides. Biocompatibility with the
cells is achieved by coating the particle surface in polyethyleneimine polymers (PEI) or
lipid bilayers (Buchman et al. 2013 and Ashley et al. 2012). PEI and lipid bilayers
eliminate electrostatic interactions and thus reduce cytotoxicity (Xia et al. 2009).
Preliminary experiments in our lab indicated that lipid bilayers limit uptake of pSNPs
into insect cells and so this study focuses on an aminosilane as the optimal modification
to investigate.
I investigated the use of porous silica nanoparticles, which have numerous
benefits including reduced cytotoxicity (Di Pasqua et al. 2008), high surface and internal
malleability, and possess a large dsRNA loading capacity (Möller et al. 2016). Although
nanoparticles have a low cytotoxicity, some cytotoxicity to human neuroblastoma cells
has been recorded and may be caused by the adsorptive surface area of the particle or the
properties of the functional group attached to the particle surface (Di Pasqua et al. 2008).
In some cases, PEI can cause apoptosis, but researchers have found that this may depend
on cell type and the molecular weight of the PEI molecules (Florea et al. 2002 and Xia et
al. 2009). The pSNPs utilized in this study did not contain PEI, and thus avoided the
possibility of the PEI surface modification increasing apoptosis. The surface area of the
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nanoparticles utilized in this study are amine functionalized pSNPs ranged from 14.4 to
585 m2/g, which ensured that there were sufficient binding sites for dsRNA molecules.
M. Arif Khan produced three pore sizes of pSNPs: 1.58 ± 0.14 nm, 3.24 ± 0.38 nm, and
7.55 ± 1.92, with pore volumes of 0.57, 0.66, and 1.50 cm3/g, respectively. This
capability provides this study with a range of pSNPs for study with pores equal to and
larger than the diameter of dsRNAs. Fluorescently labeled dsRNAs of three sizes: 84
base pairs (bp), 184 bp, and 282 bp were made that were also biologically relevant, from
slightly larger than siRNAs to sizes that are routinely used for gene silencing experiments
in insects (several hundred base pairs).
These 12 dsRNA/pSNP combinations were studied in detail to investigate how
nucleic acids interact with nanoparticles, how these interactions influence the protection
and delivery qualities of nanoparticles, and how this information can be applied in vivo in
insect cells. This information is critical to design and synthesis of a functional
nanoparticle delivery system that is required to make RNAi an effective strategy for
control of insects that do not respond robustly to dsRNAs. Understanding the
interactions of nanoparticles, nucleic acids, and the cells they are delivered to is critical
for maximizing chances of success and troubleshooting initial failures that are to be
anticipated in the design of a functioning dsRNA delivery system for control of a wide
spectrum of insect pests.
Impact and Big Picture
Prior work has shown that nanoparticles loaded with dsRNA can be used to
weaken insects before insecticide treatment (Zhang et al. 2010 and He et al. 2013),
suggesting that a combination of RNAi and insecticide treatment could represent an
integrative management strategy that delays the development of insecticide resistance in
10

target pest species. Beyond weakening insects to insecticides, nanoparticles may be
useful in RNAi to enhance protection of dsRNA from degradation and uptake by insect
cells. There are many types of nanoparticles that can be used, including chitosan, metals
like silver and gold, and other nontoxic polymers, but we chose to use silica nanoparticles
because they are nontoxic and easy to manipulate (Zhang et al. 2010). In addition to the
low impact to non-target species, silica nanoparticle technology could be applied to
RNAi-insensitive insects to induce an RNAi response. Enhancing siRNA delivery may
enhance RNAi efficacy, but there may still be other factors restricting the use of RNAi as
a control strategy in RNAi-insensitive insects. If that is the case, then nanoparticles could
still be used to control RNAi-sensitive insects. This technology is easy to manipulate and
could be used as a new form of pest control. To study this new technology, we
collaborated with Dr. Barbara Knutson and Dr. Steve Rankin from the Department of
Engineering at the University of Kentucky and developed the following three objectives
that comprise the body of this thesis.

Objective 1: Characterize the binding and dissociation properties of RNA to porous
and nonporous silica nanoparticles.
Objective 2: Characterize the ability of porous and nonporous silica nanoparticles to
protect dsRNA against cellular RNase activity.
Objective 3: Analyze efficacy of RNA and silica nanoparticle complexes to induce an
RNAi response in Spodoptera frugiperda cells.
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Chapter Two: dsRNA Interactions with Porous Silica Microparticles: RNA
Binding and Mobility
INTRODUCTION
Nanoparticles, microscopic particles measuring between 10 nanometers (nm) and
1000 nm, have been used to deliver nucleic acids and proteins to eukaryotic cells and
organisms, both plant and animal (He et al. 2013; Zhang et al. 2010; Xia et al. 2009;
Torney et al. 2007). In insects, nanoparticles have been investigated for their potential to
deliver nucleic acids to several species with some success (He at al. 2013; Zhang et al.
2010; Thairu et al. 2017; Das et al. 2015). However, ‘nanoparticle’ is a general, sizebased, descriptive term for an array of particles having divergent characteristics, diverse
compositions and under-studied chemistry. Nanoscale interactions between nucleic acids
and nanoparticles are likely to exhibit novel phenomena and characteristics, providing
strong rationale for the systematic investigation of the physicochemical interactions
between nanoparticles and nucleic acids of specific composition and sequence. Further,
some classes of nanoparticles, having physicochemical properties that can be controlled
and modified, may be engineered for properties that support their use as carriers of
biological macromolecules. Here, we investigate the interactions between doublestranded RNA (dsRNA) and porous silica nanoparticles (pSNPs). pSNPs are versatile,
tractable nanoparticles that are readily functionalized and bind to a variety of molecules,
such as nucleic acids, pharmaceuticals, and lipids. pSNPs are also highly biocompatible
with cells, in that they can easily pass through cell membranes and safely deliver
molecules associated with the nanoparticle to the cell’s interior (Möller et al. 2016).
pSNPs are highly suited to macromolecule delivery because pore size can be controlled,
surface characteristics predictably modified and they have a large nucleic acid loading

12

capacity (Möller et al. 2016). Here we investigate the relationship between dsRNA and
pSNPs under selected, biologically relevant conditions.
The potential for pSNPs to deliver protein to cells and protect cargo proteins from
proteases was studied because these characteristics are relevant to the use of pSNPs for
delivery of proteinaceous drugs, as well as use for chemical syntheses, as biosensors, and
in bioseparations (Schlipf et al. 2013). pSNPs were shown to readily take up proteins and
protect them from protease digestion in a pore-size dependent manner. Similarly, pSNPs
were assessed for their ability to take up RNA by Möller et al. (2016) and nucleic acids
were shown to bind to amine functionalized pSNPs. While the associations between
pSNPs and proteins were clearly impacted by protein size, the characteristics of the
nucleic acid partner in pSNP-dsRNA interactions are not well defined in the published
literature. More generally, the potential for other types of nanoparticles to deliver
dsRNA to insects has been assessed in a limited number of non-coleopteran pests in
hopes of expanding the efficacy of RNAi (Zhang et al. 2010; He at el. 2013; Das et al.
2015; Thairu et al. 2017). But again, the impacts of dsRNA length or sequence
composition have not been investigated.
Delivery of dsRNA to insect cells is of interest because of its potential to induce
an RNA interference (RNAi) response. RNAi is an immune system in all eukaryotic
cells that recognizes and degrades exogenous double-stranded RNA (dsRNA). The
RNAi system is also used to regulate gene expression in many Eukaryotes and for
suppressing gene expression for research and commercial purposes (Baum et al. 2007).
When cells encounter dsRNA of a viral or artificial origin, gene silencing occurs through
activation of ribonucleases that target the sequence of the dsRNA encountered by the
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cell’s RNAi machinery (Bernstein et al. 2001). Initially, foreign dsRNAs are recognized
and cleaved into short, 21-23 base pair (bp), double-stranded molecules (small interfering
RNAs or siRNAs) by the ribonuclease DICER (Bernstein et al. 2001). These siRNAs are
loaded into the RNA-induced silencing complex (RISC) where one strand is degraded
and the other, called the guide strand, is used to identify complimentary, native mRNAs
(Hammond et al. 2001). Once a cellular mRNA is recognized by the siRNA/RISC
complex, RISC cleaves the mRNA and the mRNA is degraded.
Potentially, RNAi may be useful for the control of insect pests, but researchers
have found that RNAi efficacy is highly variably for suppression of targeted genes
among several insect orders (Lim et al. 2016). For instance, dsRNA can be designed to
target essential insect mRNAs such as those required for feeding and detoxication of
pesticidal proteins, thus RNAi can decrease fitness and increase mortality (Baum et al.
2007). This approach, while highly efficient in some species, such as coleopterans,
others, notably lepidopterans, show little or no RNAi response (Bellés, 2010; Gatehouse
and Price, 2011; Baum and Roberts, 2014; Huvenne and Smagghe, 2010). There are
three main hypotheses for why RNAi produces less effective responses in lepidopterans.
The first is that coleopterans, which produce robust RNAi responses, contain dsRNA
cellular import and export mechanisms while lepidopterans do not. A second hypothesis
is that RNAi signal amplification, a process whereby cells exposed to exogenous dsRNA
can amplify RNAi signals with an RNA-dependent RNA polymerase, which is necessary
for systemic RNAi responses, is reduced or absent in lepidopterans (Gatehouse and Price,
2011). The third hypothesis is that high levels of nuclease activity are found in
lepidopteran cells and hemolymph (and presumably in other insect orders with reduced
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RNAi responses) and these RNases degrade dsRNA before it encounters target cells
(Bellés, 2010; Gatehouse and Price, 2011; Gu and Knipple, 2013; Terenius et al. 2011).
If the barriers to the effective use of RNAi in insects could be overcome, RNAi could
become an advantageous technology for the control of lepidopterans and other insect
pests.
One potential strategy to efficiently and effectively deliver dsRNA to insect cells
is to engineer the nanoparticle so that it becomes an improved dsRNA delivery vehicle.
Conventionally, dsRNA has been delivered to insect cells and insects by microinjection
of RNA, ingestion of RNA, or soaking the insect or insect cells in an RNA-containing
solution. Other, less conventional methods, such as electroporation, liposome
encapsulation, and in planta RNA expression have also been explored (Karim et al. 2010;
Whyard et al. 2009; Zhang et al. 2013). However, most nanoparticles are relatively
fixed in their physicochemical properties and little effort has been directed to optimize
nanoparticle properties to support efficient dsRNA delivery to insect cells or insects.
There are several criteria to be considered for optimization of nanoparticles for
dsRNA delivery, notably pSNP charge, nanoparticle and pore size, and the presence or
absence of membranes on the pSNP surface. To enhance association between
nanoparticles and dsRNA, nanoparticles are amine functionalized, thereby coating the
nanoparticle with a positive charge. The positive charge may be conveyed by molecules
such as aminosilane, metal ions, cationic polymers and peptides (Xiong et al. 2016 and
Lin et al. 2013). Nanoparticles can also be coated with polyethyleneimine (PEI)
polymers or supported bilayers, which eliminate electrostatic interactions between
negatively charged dsRNA molecules and negatively charged cell membranes (Buchman
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et al. 2013 and Ashley et al. 2012). When specific cells are being targeted, nanoparticles
may be coated with particular ligands or peptides to enhance binding (Tarn et al. 2013).
Because there is some data indicating that silica nanoparticles are not cytotoxic in
mammalian cells (Di Pasqua et al. 2008), the nanoparticle and pore size can be controlled
and they are readily amidated by aminosilane treatment, these particles were selected for
study.
Design and synthesis of nanoparticles for dsRNA delivery should be based upon
an understanding of interactions between dsRNA length, dsRNA concentration, and
pSMP pore size. However, nanoparticle properties are difficult to visualize and study by
light microscopy because of their size. To more effectively visualize and understand
dsRNA-pSNP interactions, we utilized microparticles, which have diameters between 5
µm to 15 µm and are thus large enough to be seen with confocal microscopy, and so are
amenable to analyses using confocal microscopy such as fluorescence recovery after
photobleaching (FRAP) analysis. Thus, microparticles are a model for nanoparticle-RNA
interactions that allow us to visualize and describe the system. Because the
microparticles and nanoparticles have the same surface functionality, are made of the
same materials, and have equivalent pore sizes, the information gathered in investigations
of microparticle-RNA interactions is directly relevant to the design and optimization of
nanoparticle-RNA interactions.

MATERIALS AND METHODS
Cell Culture
To gather Sf9 DNA, Sf9 cells were cultured in Sf-900 II serum-free media
(GibcoTM Cell Culture) per established protocols (O’Reilly et al. 1994). Cells were
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maintained and passaged as adherent monolayer cultures in 25 cm2 tissue-culture flasks
(Corning, Corning, NY) at 32°C. Cell density and viability was determined using a
Trypan Blue dye exclusion assay and a hemocytometer.
Synthesis of dsRNA
Sf9 DNA was extracted from cultured cells by phenol-chloroform extraction
(Thermo Fisher Scientific, Waltham, MA) per the manufacturer’s protocol, and this DNA
was used in PCR reactions to amplify the defined sections of the IAP gene. To
synthesize dsRNAs of several lengths, segments of the Spodoptera frugiperda Inhibitor
of Apoptosis (IAP) gene (GenBank: AF 186378.1) were amplified using the PCR and
IAP sequence-specific primers containing T7 promoters. dsRNAs were then synthesized
from PCR templates by in vitro transcription. Table 2.2 contains the specific primer
sequences used to amplify two segments of the IAP gene: IAP84 (84 bp), and BIR2 (282
bp) amplicons. These two RNA sizes were selected to allow transcription of dsRNAs of
a size like silencing RNAs after processing by DICER and to larger RNAs typically used
to activate RNAi responses in insects. The IAP gene was chosen because when IAP
dsRNA is used in RNAi, a characteristic phenotypic apoptotic response is induced
(Bernsetin et al. 2001 and Tuschl et al. 1999). BIR2 is a functional domain within the
coding sequence of the IAP gene, and IAP84 is a segment of the BIR2 domain (Huang et
al. 2000). Each 25 µL PCR reaction was prepared at room temperature and contained the
following: 2.5 µL 10X PCR buffer, 1.5 µL MgCl2 (50 mM), 2.0 µL dNTP mix (10 mM),
0.5 µL forward primer (100 mM), 0.5 µL reverse primer (100 mM), 0.25 µL Taq
Polymerase (Invitrogen, Waltham, MA), 1.0 µL Sf9 DNA, and 16.75 µL nuclease-free
H2O. PCR reactions were run on a PTC-200 DNA Engine (Bio-Rad, Hercules, CA) with
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the following cycling parameters: initial denaturation at 95°C for 30 sec, followed by 30
cycles of denaturation at 95°C for 30 sec, annealing at 58°C for 30 sec, and extension at
68°C for 30 sec, and a final extension incubation at 68°C for 5 min.
Five µL of each PCR product was analyzed on a 1.75% agarose gel to confirm
that amplicons were of the designed product length. For dsRNA synthesis, PCR products
for IAP84 and BIR2 were purified using the Fermentas GeneJET PCR Purification Kit
(Fermentas, Waltham, MA) per the manufacturer’s protocol.
Fluorescently labelled BIR2 and IAP84 dsRNAs were synthesized using the
HiScribe T7 High Yield RNA Synthesis Kit (New England Biolabs, Ipswich, MA). The
reaction mixture was prepared at room temperature and contained the following: 2.0 µL
10X T7 reaction buffer, 2.0 µL ATP (100 mM), 2.0 µL GTP (100 mM), 2.0 µL CTP (100
mM), 1.5 µL UTP (100 mM), 0.5 µL fluorescein-12-UTP (250 nmol, Roche, Basel,
Switzerland), approximately 10 ng purified PCR product template, 2.0 µL T7 RNA
polymerase mix, and nuclease-free H2O. The final volume was 20 µL. Samples were
vortexed and incubated at 37°C overnight.
After the overnight incubation, dsRNA samples were left at room temperature for
5 min to allow for annealing of single stranded RNA molecules. Newly synthesized
dsRNA samples were quantified on a NanoDrop 2000 Spectrophotometer (Thermo Fisher
Scientific, Waltham, MA) and then diluted 1:4 in nuclease-free H2O. 7.2 µg of each
diluted sample was combined with nuclease-free H2O for a total volume of 31 µL. Size
and purity of dsRNA samples were then verified on 2% agarose gels.
Mesoporous Silica Microparticle Solutions
Santa Barbara amorphous silica batch nonporous microparticles (SMPs) and silica
mesoporous microparticles (pSMPs) were synthesized and provided by Shanshan Zhou in
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the lab of Dr. Barbara Knutson and Dr. Steve Rankin using methods modified from those
described by Schlipf et al. (2013). Detailed description of the syntheses of SMP and
pSMP synthesis are provided elsewhere (Appendix A). Four types of microparticles
were synthesized: amine functionalized nonporous silica particles, amine functionalized
pSMPs with an average pore size of 3.0 ± 0.9 nm (“3.6 nm pSMPs”), amine
functionalized pSMPs with an average pore size of 7.2 ± 1.2 nm (“7.4 nm pSMPs”), and
amine functionalized pSMPs with an average pore size of 11.3 ± 3.0 nm (“11.8 nm
pSMPs”). The particle name is based on pore sizes of these particles prior to amine
functionalization. The average pore size after amine functionalization is somewhat
smaller than the particle names. Microparticle stock solutions were made up in
concentrations of 10 mg/mL in nuclease-free H2O. Before use, pSMP stock solutions
were sonicated using a Tekmar Sonic Disruptor for 15 seconds (Teledyne Tekmar,
Mason, OH) to resuspend particles in the solution. After the initial sonication, all pSMP
solutions were vortexed with a Vortex Genie 2 (Thermo Fisher Scientific, Waltham, MA)
for 15 seconds immediately before use.
dsRNA Loading onto Microparticles
To support dsRNA binding to pSMPs, the pSMPs were positively charged by
amine functionalization (Appendix A). dsRNAs will then bind to pSMPs in aqueous
solutions ranging from pH 5-9. dsRNA was bound to pSMPs by adding 0.25 mg dsRNA
to 0.25 mg pSMP. To track RNA binding to microparticles in these studies, 1 µL of
fluorescently labeled IAP84 (concentration=12.67495 µg/µL) was added to RNA
solutions before allowing the RNA to associate with microparticles. This allowed
visualization of microparticle-RNA binding and mobility. Five µL of each of the four
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types of microparticles (concentration=10 mg/mL) were combined with 14 µL of RNasefree H2O. Samples were vortexed and shaken on a 55S 12 x 16 Single Platform
Laboratory Shaker (Reliable Scientific, Nesbit, MS) at 40 rpm at room temperature for
one hour to allow for dsRNA attachment. To remove any unbound dsRNA in solution,
samples were centrifuged for 20 seconds to pellet the pSMP/dsRNA complexes (Thermo
Fisher Scientific, Waltham, MA) and aqueous supernatants were removed from each
sample and discarded. To wash dsRNA/pSMP complexes, 47 µL of RNase-free H2O was
added to each sample, which was then vortexed and centrifuged, and then the aqueous
fraction was removed as described above. The washing step was repeated 3 times.
Finally, samples were spun down in a microcentrifuge at 6,300 x g (Thermo Fisher
Scientific, Waltham, MA) for 30 seconds to pellet the pSMP/dsRNA complexes, which
were then assessed by confocal microscopy.
Photobleaching to Measure Fluorescence Recovery
Fluorescein-12-UTP labeled dsRNA was excited at 488 nm with an argon laser at
8% laser power for imaging. Emission was collected between 500 nm and 600 nm.
Photobleaching experiments were performed at 20°C over a x63/1.3 oil immersion
objective. One image was captured prior to bleaching. Then, a 500-nm diameter disk
was bleached once at 75% laser power. Five images were captured at the fastest capture
rate of 1.3 seconds, five images were captured at 3 second intervals, and finally 20
images were captured at 10 second intervals. All imaging and fluorescence recovery
after photobleaching (FRAP) experiments were conducted on a Leica TCS SP5 Confocal
Microscope (Leica Microsystems, Wetzlar, Germany).
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RESULTS AND DISCUSSION
To investigate the potential for pSNPs to associate with and deliver RNA to cells,
this study used micron-sized particles having pores of similar dimensions to pSNPs. A
similar approach was used by Schlipf et al. (2013) to investigate binding of proteins to
porous silica micro- and nanoparticles and protection of bound proteins from proteolysis.
As the physical characteristics of dsRNA, a predominantly linear molecule, and globular
proteins differ significantly, RNA and silica nanoparticles may interact in very different
ways. Further, the features of RNA length and sequence composition may also impact
dsRNA-pSNP interactions.
To investigate the relationship between dsRNA and porous silica microparticles
(pSMPs), dsRNAs of two lengths were synthesized (84 base pairs [bp] and 282 bp). The
size of these dsRNAs was selected to mimic and allow the study of short dsRNAs that are
like silencing RNAs produced by DICER catalysis and larger RNA templates typically
used to activate the DICER system. These RNA targets were designed from the S.
frugiperda IAP gene as suppression of genes that inhibit apoptosis in cells induces
apoptosis, thereby producing a visible phenotype. Concurrently, four types of amine
functionalized pSMPs (nonporous, 3.6 nm porous, 7.4 nm porous, and 11.8 nm porous)
were synthesized to study the effects that pores of differing sizes have on RNA-silica
particle interactions. These pore sizes were selected with consideration for the 2-nm size
of double-stranded nucleic acids and expected to provide restricted access at the 3.6 nm
pore size and relatively free access at the larger pore sizes. Finally, we labeled a fraction
of dsRNAs with a fluorescein-12-UTP nucleotide to allow visualization of the RNA
partner in these association studies and optimized relative concentrations of dsRNA and
pSMPs. The results of these preliminary experiments were to standardize conditions for
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the study of pSMP-dsRNA interactions. Briefly, the RNA and silica particles were used
at a concentration of 0.25 mg dsRNA/mg pSMPs, in neutral, aqueous solution. The
fluorescein-labeled dsRNA used for visualization by confocal microscopy was otherwise
identical to the unlabeled dsRNA and represented 6.25% of the dsRNA in experiments.
Loading Silica Microparticles with Labeled dsRNA
Figure 2.1 shows dsRNA loading of dsRNAs of 282 and 84 bp onto the selected
types of particles. The images are optical sections of the microparticles with fluorescence
showing the locations of bound RNA. Only surface binding was present for both
dsRNAs when bound to nonporous microparticles. Nonporous particles lack interior
pores and as expected, only surface binding is evident in this experiment. In contrast, the
shorter dsRNA, IAP84 (84 bp) was evident throughout pSMPs of all classes (3.6 nm
pSMPs, 7.4 nm pSMPs, and 11.8 nm pSMPs), indicating that the 84 bp dsRNA can
readily enter all three pSMP pore sizes. This result suggests that dsRNAs equal to or
smaller than 84 base pairs can efficiently enter the three pore sizes that were tested.
Interestingly, the larger 282 bp dsRNA fragment exhibited pore-size dependent
differences in pSMP binding. With 3.6 nm pSMPs, only surface binding was observed,
which was similar to binding of the RNA to nonporous particles. As pore size increased,
the BIR2 dsRNA was detected throughout the interior of the particle.
These data indicate that larger RNA (282 bp or larger) are unable to enter pores of
3.6 nm or smaller. This constraint on RNA loading suggests that dsRNAs do not readily
thread into the particle’s pores. The larger pore sizes (7.4 nm and greater) do not show
evidence of this constraint, indicating that it is not simply an issue of orienting the
dsRNA relative to the pore that influences loading. To further investigate the influence
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of dsRNA length and pore size on dsRNA loading onto pSMPs, we performed
fluorescence recovery after photobleaching (FRAP) analyses which allows the mobility
of fluorescently labeled dsRNA molecules on the pSMP to be measured (Fig. 2.2).
IAP84 Diffusivity in Different Pore Sizes of pSMPs
To assess the mobility of experimental dsRNAs that can freely enter pSMPs of all
tested pore sizes, a fluorescently labeled 84 bp dsRNA, known as IAP84, was associated
with nonporous SMPs and pSMPs that have pores of 3.6, 7.4, or 11.8 nm. FRAP utilizes
transient exposure to a laser to bleach a fluorescent area, inactivating the signal from the
labeled dsRNAs on the surface of the microparticle (Fig. 2.2). The recovery of
fluorescence, known as the diffusivity, is a direct observation of unbleached,
fluorescently-tagged dsRNA moving into the area that was bleached by exposure to the
laser. This enables the mobility of the dsRNA molecules to be measured. To assess
RNA mobility at different regions within the microparticle, optical sections can be taken
from the surface of the particle after bleaching, known as the “cap” measurement. To
measure interior mobility, optical sections within the particle, known as the “core”
measurement, can be used. Thus, dsRNA mobility, or diffusivity, can be measured on
the surface and in the interior. RNA mobility on nanoparticles may be related to the
ability of a particular class of nanoparticles to take up and release RNA. As induction of
the RNAi response requires the cell’s DICER system to detect and respond to the
presence of RNA in a cell, RNA which is not released from a nanoparticle may be less
effective in inducing an RNAi response.
When FRAP analyses were performed with the experimental dsRNAs, IAP84 and
BIR2, to measure RNA mobility on the surface of nonporous silica microparticles,
diffusivity was measured at zero (Table 2.1). These data indicate that the RNA bound so
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strongly to the particle surface that it did not move, suggesting that nonporous silica
nanoparticles may not be an optimal vehicle for delivery of dsRNA to cells.
Interestingly, when diffusivity of IAP84 and BIR2 dsRNAs were measured by FRAP
analyses these dsRNAs appeared to move readily with mobility increasing in a non-linear
manner as pSMP pore size increased (Table 2.1). This suggests that smaller dsRNAs can
move freely within a wide range of pore diameters and this conclusion is important in
designing dsRNA/pSMP complexes for the delivery of dsRNAs to insect cells.
Perhaps surprisingly when considering the lack of mobility on nonporous
particles, the IAP84 dsRNA was quite mobile at both the center of the 3.6 nm pSMP (the
“core” measurement), and at the surface of the particle (the “cap” measurement).
Diffusivity was measured at 2.45E-04 ± 5.49E-05 µm2/second for IAP84 dsRNA at the
surface of the 3.6 nm pSMP, while the “cap” measurement was 2.91E-04 ± 1.11E-04
µm2/second. Interestingly, the increase in dsRNA mobility increased disproportionately
to the increase in pore size; a 2.84-fold increase in mobility was observed with a
doubling in pore size from 3.6 to 7.4 nm, whereas the increase from 7.4 to 11.8 nm
resulted in an increase that was more proportional to the increase in pore size. Core
mobility of IAP84 dsRNA associated with the 7.4 nm pSMP was 8.47E-04 ± 1.85E-04
µm2/second. Cap mobility of IAP84 dsRNA associated with the 7.4 nm pSMP was
8.26E-04 ± 2.66E-04 µm2/second. The core mobility of IAP84 dsRNA associated with
the 11.8 nm pSMP was 1.29E-03 ± 2.65E-04 µm2/second. Cap mobility of IAP84
dsRNA associated with the 11.8 nm pSMP was 1.25E-03 ± 8.44E-05 µm2/second (Table
2.1 and Fig. 2.3). The cap and core measurements for each pore size were not
significantly different for any pSMP, regardless of pore size (p-value for 3.6, 7.4, and
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11.8 nm samples: 0.48425, 0.90234, 0.78468, respectively). This indicates that there is a
relationship between cap and core mobility, namely that the presence of dsRNA inside
the particle enables movement of dsRNA on the surface of particles.
BIR2 Diffusivity in Different Pore Sizes of pSMPs
To further study the relationship between dsRNA length, pore size, and dsRNA
diffusivity, BIR2 dsRNA (282 bp) was investigated. These two lengths were chosen
because they are the same functional domain of the IAP gene, with IAP84 residing within
BIR2. Fluorescently labeled BIR2 dsRNA was combined with nonporous, 3.6 nm
porous, 7.4 nm porous, and 11.8 nm porous silica microparticles at a ratio of 0.25 mg
dsRNA/mg pSMP. The same FRAP experiment utilized in the IAP84 dsRNA mobility
experiment was performed with the BIR2 dsRNA (Fig. 2.2). BIR2 dsRNA showed no
diffusivity, which is a direct measurement of mobility, on the cap or core of 3.6 nm
pSMPs and on the cap of nonporous SMPs. Core mobility of BIR2 dsRNA associated
with the 7.4 nm pSMPs was 1.45E-04 ± 4.75E-05 µm2/second. Cap mobility of BIR2
dsRNA associated with 7.4 nm pSMPs was 1.69E-04 ± 5.71E-05 µm2/second. Core
mobility of BIR2 dsRNA associated with 11.8 nm pSMPs was 4.96E-04 ± 1.99E-04
µm2/second. Cap mobility of BIR2 dsRNA associated with 11.8 nm pSMPs was 4.87E04 ± 1.96E-04 µm2/second. These values are recorded in Table 2.1 and Figure 2.4. The
cap and core measurements for each pore size were not significantly different for any
pSMP, regardless of pore size (p-value for 7.4 and 11.8 nm samples: 0.54215 and
0.95343, respectively). Although mobility of BIR2 dsRNA was detected in the 7.4 nm
and 11.8 nm pSMPs, the recorded diffusivity values are lower than the diffusivity values
for IAP84 dsRNA (Table 2.1). This indicates that diffusivity and dsRNA mobility
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decreases as dsRNA length increases, suggesting that there are limits on the length of
dsRNA that will exhibit mobility on pSMPs.
Diffusivity of IAP84 dsRNA at Varying Concentrations in Association with
11.8 nm pSMPs
To test the effects of dsRNA concentration on mobility, the most mobile
dsRNA/pSMP combination, fluorescently labeled IAP84 dsRNA with 11.8 nm pSMPs,
was tested by FRAP analyses at three concentrations: 0.25 mg dsRNA/mg 11.8 nm
pSMPs (which is the concentration used in the previous experiment), 0.13 mg dsRNA/mg
11.8 nm pSMPs, and 0.07 mg dsRNA/mg 11.8 nm pSMPs. Initially, we investigated
how different concentrations of dsRNA effected loading on the particle. Interestingly, at
0.07 mg/mg, only surface binding is observed and the bound dsRNA is not mobile.
Fluorescent dsRNA is not detected inside the particle. However, at twice this
concentration, 0.13 mg/mg, surface binding and ubiquitous internal binding are observed.
At four times the initial concentration, 0.25 mg/mg, strong surface binding and uniform
internal binding are observed, as indicated by the presence and brightness of the
fluorescent signal (Fig. 2.5).
FRAP analyses were then used to measure dsRNA diffusivity. As dsRNA
concentration increased, dsRNA mobility on the surface and in the interior of 11.8 nm
pSMPs increased (Table 2.3 and Fig. 2.6). Cap and core mobility of IAP84 dsRNA in
association with 11.8 nm pSMPs at a concentration of 0.07 mg dsRNA/mg pSMP was
0.00 µm2/second. Core mobility of IAP84 dsRNA in association with 11.8 nm pSMPs at
a concentration of 0.13 mg dsRNA/mg pSMP was 4.02E-04 ± 2.80E-04 µm2/second.
Cap mobility of IAP84 dsRNA in association with 11.8 nm pSMPs at a concentration of
0.13 mg dsRNA/mg pSMP was 2.16E-04 ± 7.78E-05 µm2/second. At the highest
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concentration used, 0.25 mg/mg, the dsRNA was highly mobile on the cap and in the core
of the 11.8 nm pSMPs. The core diffusivity was 1.29E-03 ± 2.65E-04 µm2/second. The
cap diffusivity was 1.25E-03 ± 8.44E-05 µm2/second. The cap and core measurements
for samples were not statistically different (p-values for 0.13 mg/mg and 0.25 mg/mg:
0.24571 and 0.78468, respectively). Taken together, these results indicate that not only
do dsRNA length and particle pore size influence mobility, but also that dsRNA mobility
is concentration-dependent. Thus, it is necessary to optimize dsRNA length,
concentration, and pSMP pore size to maximize dsRNA diffusivity and thus mobility.
Porous silica nanoparticles are excellent candidates for dsRNA delivery to insect
cells for several reasons. Pore size can be easily manipulated, surface characterizations
can be changed, they possess strong biocompatibility with cell membranes, they can be
manipulated to hold large volumes of molecules, and they are cheap and easy to produce
(Möller et al. 2016). Many of these qualities can be studied in equivalent mesoporous
silica microparticles, which are large enough to be observed with confocal microscopy.
We began this study with the intention of characterizing the relationship between dsRNA
size and particle pore size in relation to loading, and in turn observed dsRNA mobility.
Using FRAP, we discovered the unique relationship between dsRNAs of different
lengths, microparticles with different sized pores, and dsRNA concentration.
Both pSMP pore size and dsRNA length influenced dsRNA mobility. The shorter
dsRNA, IAP84 (84 bp) had consistently higher mobility than the larger dsRNA, BIR2
(282 bp). For both dsRNA lengths, mobility increased as pore size increased and the
mobility was not significantly different between the cap and core measurements. In
contrast, no diffusivity was recorded for either dsRNA length on nonporous SMPs. This
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suggests that it is important for a particle to contain a network of pores to serve as a
‘sink’ to aid in dsRNA mobility on the surface of the particle. After establishing that the
IAP84 dsRNA was the most mobile in 11.8 nm pSMPs and was more mobile than BIR2
dsRNA, we tested the effect that dsRNA concentration had on dsRNA mobility. As
dsRNA concentration increased, mobility also increased. This suggests that dsRNA
mobility is not only influenced by dsRNA length and pSMP pore size, but also by dsRNA
concentration.
Protein delivery by silica nanoparticles is studied for applications in drug
delivery, chemical synthesis, biosensors, and bioseparations (Schlipf et al. 2013). The
Schlipf et al. (2013) study utilized similar methods, namely confocal microscopy, to
elucidate the relationship between protein molecules and mesoporous silica
microparticles. They discovered that, under certain conditions, enhanced green
fluorescent protein (EGFP) molecules could be inactivated by Pepsin A when not fully
protected by pores (Schlipf et al. 2013). This experiment went further in studying the
protection properties of porous microparticles and discovered that an optimal pore size
that allows EGFP to be protected while excluding Pepsin A is possible, which lends itself
well to the second application in our work. Once we discovered that smaller dsRNA can
enter pores and have high mobility, we began studying the protection properties of pores
against degradation by RNase III (see Chapter 3). This information is critical in
designing particles for molecule delivery.
Several delivery methods for siRNAs have been researched, including polymers,
liposomes, dendrimers, hydrogels, and inorganic host systems (Wang et al. 2010 and
Draz et al. 2014). One paper investigated the relationship between amine functionalized
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porous nanoparticles and dsRNAs (Möller et al. 2016), although they used siRNAs which
were smaller than the RNAs tested in this study. They showed that nanoparticles with 4
nm pores were capable of binding large amounts of siRNA, and that, through surface
manipulation, these nanoparticles could successfully deliver their siRNA loads to
cancerous cells. Although Möller et al. (2016) established useful methods for
manipulating particle pore size and surface characterization for the association of dsRNA,
they did not investigate the diffusivity of siRNA molecules in nanoparticles.
In insect pest management, nanoparticle studies have focused on toxicity and
enhancing the use of pesticides with metal nanoparticles (Afrasiabi et al. 2016;
Kucharska et al. 2016; Allahvaisi, 2016; Pappas et al. 2017; Meng et al. 2017). It is
important to note that numerous types of nanoparticles exist, all with their own unique
properties. Several articles have explored the stability of dsRNA when associated with
different types of nanoparticles and how this effects RNAi efficacy (He at al. 2013;
Zhang et al. 2010; Thairu et al. 2017; Das et al. 2015). What these studies lack is the
fundamental investigation into the relationship between dsRNA and nanoparticles, before
these complexes enter insects and their cells. That is the gap which we address with this
study.
This information about how dsRNA size, dsRNA concentration, and pore size
influence dsRNA mobility is critical to designing a nanoparticle delivery system for
introducing dsRNA into insect cells. Without this fundamental knowledge, nanoparticle
delivery experiments have a high risk for failure that is not due to the efficacy of dsRNA
but to the failure of the delivery system. Future directions for this work are to assess in
vitro and in vivo functionality. Diffusivity data can be assessed in vitro by exposing

29

dsRNA/nanoparticle complexes to nucleases found in cells. If dsRNAs are short enough
to fully load nanoparticles and have high mobility, nanoparticles can protect dsRNA from
degradation and the highly mobile dsRNA can leave the nanoparticle once inside insect
cells. This optimized system can be evaluated in insect cells. Many assays are
commercially available for assessing in vivo functionality, and we utilized a phenotypic
assay that relied on nuclear staining and fluorescent microscopy of cells after being
exposed to dsRNA/nanoparticle complexes.
To characterize the mobility of dsRNA in mesoporous silica microparticles, two
dsRNA lengths and four types of silica microparticles were used. Using confocal
microscopy and fluorescence recovery after photobleaching, we determined that
diffusivity was highest for IAP84 dsRNA associated with 11.8 nm pSMPs. We then used
different concentrations of IAP84 dsRNA in association with 11.8 nm pSMPs to establish
the role of dsRNA molecules in dsRNA mobility. This data provides more information
about the design of an effective and functional nanoparticle delivery system for dsRNA
to insect cells.
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Figure 2.1. Confocal Microscopy Images for all Four Microparticle Types Loaded
with Two dsRNA Lengths.
Confocal microscopy images for nonporous, 3.6 nm porous, 7.4 nm porous, and 11.8 nm
mesoporous silica microparticles associated with fluorescein-12-UTP double-stranded
RNA. The shorter, 84 base pair dsRNA (IAP84) showed diffuse loading throughout the
entirety of the porous microparticles and binding on the outside of the nonporous
microparticles. The longer, 282 base pair dsRNA (BIR2) showed diffuse binding
throughout the 7.4 nm and 11.8 nm porous microparticles. Only surface binding was
observed on the nonporous and 3.6 nm porous microparticles, which means that larger
dsRNA molecules are not capable of loading into the interior of 3.6 nm particles.
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Table 2.1. Diffusivity Data for IAP84 dsRNA and BIR2 dsRNA on Three Types of
Mesoporous Silica Microparticles and Nonporous Silica Microparticles.
Pore Size
Nonporous
3.6 nm

7.4 nm

11.8 nm

84 bp dsRNA
Cap
Core
0.00
0.00
2
µm /s
µm2/s
2.91 E-04
2.45 E-04
±
±
5.49 E-05
5.94 E-05
8.26 E-04
8.47 E-04
±
±
2.66 E-04
1.85 E-04
1.25 E-03
1.29 E-03
±
±
8.44 E-05
2.65 E-04

282 bp dsRNA
Cap
Core
0.00
0.00
2
µm /s
µm2/s
0.00
0.00

1.69 E-04
±
5.71 E-05
4.87 E-04
±
1.96 E-04

1.45 E-04
±
4.75 E-05
4.96 E-04
±
1.99 E-04

Diffusivity, measured in µm2/second, was not detected for the IAP84/nonporous,
BIR2/nonporous, and BIR2/3.6 nm pSMP samples. Diffusivity increased for both
dsRNA lengths as pore sized increased. IAP84 samples consistently showed higher
diffusivity in porous microparticle samples then BIR2 dsRNA. Cap and core diffusivity
measurements were not significantly different.
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Figure 2.2. Overview of the Fluorescence Recovery After Photobleaching Process
(FRAP) on Microparticles Already Loaded with dsRNA.
This figure illustrates FRAP as used to assess diffusivity of dsRNA on microparticles
already associated with dsRNA. (A) The path of the argon laser through the mesoporous
microparticle and the location of the particle where mobility measurements are taken.
(B) The fluorescence intensity, representing the movement of fluorescein-12-UTP labeled
dsRNA, at various time points: pre-bleach, when the particle is bleached, and postbleach. After approximately 40 seconds, fluorescence intensity is near to what it was
before FRAP. (C) A picture of a pSMP immediately after it’s been struck by an argon
laser (left) and the same pSMP during fluorescence recovery (right).
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Diffusivity (µm2/S)

1.80E-03
1.60E-03

Cap

1.40E-03

Core

1.20E-03
1.00E-03
8.00E-04
6.00E-04
4.00E-04
2.00E-04
0.00E+00
3.6nm

7.4nm

11.8nm

Particle Pore Size

Figure 2.3. Diffusivity Results for IAP84 dsRNA in Mesoporous Silica
Microparticles.
Average diffusivity of IAP84 dsRNA (84 bp) in three types of porous silica
microparticles measured by fluorescence recovery after photobleaching (FRAP). For
each measurement, four samples were used. Error bars represent the standard error of 4
samples. Diffusivity of the dsRNA is recorded in µm2/second. Cap and core
measurements of diffusivity were not significantly different.

34

8.00E-04
7.00E-04

Cap
Core

Diffusivity (µm2/S)

6.00E-04
5.00E-04
4.00E-04
3.00E-04
2.00E-04
1.00E-04
0.00E+00
3.6nm

7.4nm

11.8nm

Particle Pore Size

Figure 2.4. Diffusivity Results for BIR2 dsRNA in Mesoporous Silica
Microparticles.
Average diffusivity of BIR2 dsRNA (282 bp) in three types of mesoporous silica
microparticles measured by fluorescence recovery after photobleaching (FRAP). For
each measurement, four samples were used. Error bars represent the standard error of 4
samples. Diffusivity of the dsRNA is recorded in µm2/second. No diffusivity was
measured at the cap or in the core of 3.6 nm microparticles. Cap and core diffusivity
were not significantly different for the 7.4 nm and 11.8 nm microparticles.
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Table 2.2. Primers Used for PCR and Subsequent dsRNA Synthesis.
Primer Name
SfIAP_BIR2_F
SfIAP_BIR2_R
SF_IAP_84_R

Primer Sequence (5’3’)
TAATACGACTCACTATAGCTACCTCGGCCGTAGAGATGA
TAATACGACTCACTATAGTGCATATCGTGGGTGCACG
TAATACGACTCACTATAGCTCCACTTTACAGAAAGCGC

Each primer contained the T7 promoter sequence and the PCR amplification sequence (in
bold). BIR2 primers synthesized dsRNAs of 282 base pairs. The IAP84 primer was used
together with the SfIAP_BIR2_F primer and synthesized dsRNAs of 84 base pairs.
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(A)

(B)

(C)

Figure 2.5. Confocal Microscopy Images for Different Concentrations of IAP84
dsRNA Associated with 11.8 nm Mesoporous Silica Microparticles.
Confocal microscopy images for fluorescein-12-UTP labeled IAP84 dsRNA associated
with 11.8 nm porous silica microparticles at 3 different concentrations: 0.07 mg
dsRNA/mg pSMPs (A), 0.13 mg dsRNA/mg pSMPs (B), and 0.25 mg dsRNA/mg
pSMPs (C). At a dsRNA to particle ratio of 0.07 mg/mg, dsRNA was only bound to the
borders of the particle and not the interior. At a dsRNA to particle concentration twice
that, 0.13 mg/mg, dsRNA loads ubiquitously but does not move well within the particles.
At a concentration of 0.25 mg dsRNA/mg pSMPs, four times the concentration used in
panel A, loading throughout the particle is present and the dsRNA is highly mobile.
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Table 2.3. Diffusivity Data for IAP84 dsRNA Associated with 11.8 nm Mesoporous
Silica Microparticles at Three Different Concentrations.
Diffusivity
(µm2/second)
Concentration (mg dsRNA/mg pSMPs)
0.07
0.13

Cap
0.00
2.16E-04
±
7.78E-05
1.25E-03
±
8.44E-05

0.25

Core
0.00
4.02E-04
±
2.80E-04
1.29E-03
±
2.65E-04

Diffusivity of IAP84 dsRNA associated with 11.8 nm porous microparticles was recorded
at three different concentrations: 0.07 mg dsRNA/mg pSMPs, 0.13 mg dsRNA/mg
pSMPs, and 0.25 mg dsRNA/mg pSMPs. These diffusivity values were not statistically
different between the cap and core. No diffusivity was recorded for the 0.07 mg
dsRNA/mg pSMP concentration. As concentration increased, diffusivity also increased.
Diffusivity was highest at the 0.25 mg dsRNA/mg pSMP concentration. Measurements
were recorded in µm2/second.
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Diffusivity (um^2/S)

1.80E-03
1.60E-03

Cap

1.40E-03

Core

1.20E-03
1.00E-03
8.00E-04
6.00E-04
4.00E-04
2.00E-04
0.00E+00
0.07 mg/mg

0.13 mg/mg

0.25 mg/mg

dsRNA to Particle Ratio

Figure 2.6. Diffusivity Results for Selected Concentrations of IAP84 dsRNA in 11.8
nm Mesoporous Silica Microparticles.
Average diffusivity of IAP84 dsRNA (84 bp) in association with 11.8 nm porous silica
microparticles at three different concentrations measured by fluorescence recovery after
photobleaching (FRAP). For each measurement, four samples were used. Error bars
represent the standard error of 4 samples. Diffusivity of the dsRNA is recorded in
µm2/seconds. Diffusivity was not significantly different between cap and core
measurements. Diffusivity decreased as dsRNA concentration decreased, and no
diffusivity was recorded at a dsRNA to particle ratio of 0.07 mg/mg.
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Chapter Three: Protection of dsRNA from RNase III by Porous and Nonporous
Silica Nanoparticles and in vivo Applications
INTRODUCTION
Nanoparticle is a general term used to describe microscopic materials 10 nm to
1000 nm in diameter. Some classes of nanoparticles have been used to deliver molecules
to numerous eukaryotic organisms (He et al. 2013; Zhang et al. 2010; Xia et al. 2009;
Torney et al. 2007). Their utility has been investigated for delivery of chemicals and
biological macromolecules, as an alternative to toxic chemotherapy, and for other
applications.
Porous silica nanoparticles are a class of nanoparticles that provide increased
surface area for chemical binding and, depending on pore size, may offer protection
against degradation in cells and organisms (Möller et al. 2016). Protecting proteins and
nucleic acids from lytic enzymes is critical to their functional delivery for therapeutic
purposes. Protection of dsRNA is particularly important because of the ability of dsRNA
to activate DICER and trigger an RNA interference (RNAi) response. For example, in
insects, one of the main hypotheses as to why RNAi fails in some orders of insects is that
nucleases that are present in the gut and hemolymph degrade dsRNAs before they contact
target cells. Nuclease activity has been recorded in two species of lepidopterans,
Manduca sexta and Bombyx mori. Non-specific activity of ribonucleases was recorded in
the hemolymph of M. sexta by Garbutt et al. (2013). In B. mori, RNase activity was
recorded in the digestive juices and hemolymph by Liu et al. (2012). For RNAi to work
efficiently, dsRNA needs to be stable and intact until it reaches its target. One means to
ensure dsRNA protection is to deliver dsRNAs in a nanoparticle delivery vehicle that
protects against RNases. Nanoparticles meet several of these requirements as a dsRNA
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delivery vehicle, including large surface area, high dsRNA loading capacity, ease of
adapting physicochemical properties of exterior and internal surfaces, and
biocompatibility with cells (Möller et al. 2016).
Mesoporous silica nanoparticles (pSNPs) protect proteins from degradation in a
pore-size dependent manner (Schlipf et al. 2013). By utilizing the fluorescence of
enhanced green fluorescent protein (EGFP), the researchers identified the properties of
mesoporous silica particles that protect EGFP from proteolysis by Pepsin A. Because
EGFP has a diameter of 2.4 nm x 4.2 nm and Pepsin A has a diameter of 7.3 nm x 3.6
nm, they concluded that tailored pores could efficiently load EGFP while excluding
Pepsin A, thus protecting EGFP from proteolysis, in a pore size-dependent manner.
Because the globular structure of proteins and the predominantly linear structure of
dsRNA differs significantly, this work utilized a similar approach to investigate whether
pSNP pores can protect dsRNAs from RNases.
While the ability of some nanoparticles to protect dsRNA from digestion has been
studied in mammalian systems, the protection qualities of nanoparticles in insect cells
have yet to be studied. Zhang et al. (2010) and He et al. (2013) report that
dsRNA/nanoparticle complexes can weaken insects, making them more susceptible to
insecticide treatments and reducing resistance to insecticides. However, these researchers
did not study in vitro relationships between dsRNA and nanoparticles before feeding the
complexes to insects. Thus, a gap exists in our basic knowledge and applied technologies
relevant to the design and use of nanoparticles for insect control.
If pSNPs that protect dsRNAs from nuclease degradation are identified, there are
other requirements for efficacious use of these nanoparticle/dsRNA complexes for insect
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control. The dsRNA/pSNP complexes must be taken up by insect cells and activate
RNAi responses in insect cells and insects. A common assay for efficacious dsRNA
delivery to cells and organisms is to target expression of genes that inhibit apoptosis.
Inhibiting such genes, such as the Inhibitor of Apoptosis (IAP), activates apoptosis in
cells, which is evident by cell lysis and associated cellular processes such as DNA
fragmentation. Apoptosis assays in several forms are commercially available and include
cell death detection by ELISA, Annexin V assays that rely on the staining of
phosphatidylserine, and nuclear dyes to observe the structure of the nucleus. We
assessed apoptotic responses by live cell imaging in combination with fluorescent
microscopy to observe if nuclear changes indicating apoptosis were induced by
pSNP/IAP dsRNA complexes in this study.

MATERIALS AND METHODS
Cell Culture
Sf9 cells were cultured in Sf-900 II serum-free media (GibcoTM Cell Culture) per
established protocols (O’Reilly et al. 1994). Cells were maintained and passaged as
adherent monolayer cultures in 25 cm2 tissue-culture flasks or as shaker flasks in 125 mL
polycarbonate Erlenmeyer flasks with vent caps (Corning, Corning, NY) at 32°C. Cell
density and viability was determined using a Trypan Blue dye exclusion assay and a
hemocytometer.
Synthesis of dsRNA
Sf9 DNA was extracted from cultured cells using phenol-chloroform extraction.
This DNA was then used in PCR to amplify selected functional domains of the Inhibitor
of Apoptosis (IAP) gene. To synthesize dsRNAs of three lengths, segments of the
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Spodoptera frugiperda IAP gene (GenBank: AF186378.1) were amplified with the PCR
and IAP sequence specific primers that also contained T7 promoters. Three dsRNAs
were then synthesized from the PCR template DNA by in vitro transcription. Table 3.1
shows primers used to amplify three segments of the IAP gene: IAP84 (84 base pairs
[bp]), really interesting new gene (RING) (184 bp), and second baculovirus IAP repeat
(BIR2) (282 bp) (Borden and Freemont, 1996). Both RING and BIR2 are functional
domains within the coding sequence of the IAP gene identified by Huang et al. (2000).
IAP84 resides within BIR2. Each 25 µL PCR reaction was prepared at room temperature
and contained the following: 2.5 µL10X PCR buffer, 1.5 µL MgCl2 (50 mM), 2.0 µL
dNTP mix (10 mM), 0.5 µL forward primer (100 mM), 0.5 µL reverse primer (100 mM),
0.25 µL Taq Polymerase (Invitrogen, Waltham, MA), 1 µL Sf9 DNA, and 16.75 µL
nuclease-free H2O. PCR reactions were run on a PTC-200 DNA Engine (Bio-Rad,
Hercules, CA) with the following cycling parameters: initial denaturation at 95°C for 30
sec, followed by 30 cycles of denaturation at 95°C for 30 sec, annealing at 58°C for 30
sec, and extension at 68°C for 30 sec, and a final extension incubation at 68°C for 5 min.
Five µL of each PCR product was analyzed on a 1.75% agarose gel to confirm
that amplicons were of the designed product length. For dsRNA synthesis, PCR products
for IAP84 and BIR2 were purified using the Fermentas GeneJET PCR Purification Kit
(Fermentas, Waltham, MA) per the manufacturer’s protocol. The RING PCR product
was excised from the gel with a razor blade and purified from the excised band using the
Qiagen QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany).
Fluorescently labeled BIR2 and IAP84 dsRNA was synthesized using the
HiScribe T7 High Yield RNA Synthesis Kit (New England Biolabs, Ipswich, MA). The
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reaction mixture was prepared at room temperature and contained the following: 2.0 µL
10X T7 reaction buffer, 2.0 µL ATP (100 mM), 2.0 µL GTP (100 mM), 2.0 µL CTP (100
mM), 1.5 µL UTP (100 mM), 0.5 µL fluorescein-12-UTP (250 nmol, Roche, Basel,
Switzerland), approximately 10 ng purified PCR product template, 2.0 µL T7 RNA
polymerase mix, and nuclease-free H2O. The final volume was 20 µL. Samples were
vortexed and incubated at 37°C overnight. Fluorescently labeled RING dsRNA was
prepared in the same manner, except that purified PCR samples were first heated to 65°C
and cooled to 42°C, after which 8 µL was added to each reaction mixture. Nonfluorescently labeled RING dsRNA was made with the same HiScribe T7 High Yield
RNA Synthesis Kit (New England Biolabs, Ipswich, MA) and PCR template. The
reaction mixture was prepared at room temperature and contained the following: 2.0 µL
10X T7 reaction buffer, 2.0 µL ATP (mM), 2.0 µL GTP (100 mM), 2.0 µL CTP (100
mM), 2.0 µL UTP (100 mM), 2.0 µL T7 RNA polymerase mix, and nuclease-free H2O.
Approximately 10 ng of purified RING PCR template was first heated to 65°C and
cooled to 42°C, after which 8 µL was added was added to the reaction mixture. The
mixture was vortexed and incubated at 37°C overnight.
After incubation, newly synthesized dsRNA samples were quantified on a
NanoDrop 2000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA) and then
diluted 1:4 in nuclease-free H2O. 7.2 µg of each diluted sample was combined with
nuclease-free H2O for a total volume of 31 µL. Size and purity of dsRNA samples were
verified on 2% agarose gels.
Mesoporous Silica Nanoparticle Solutions
Mesoporous silica nanoparticles (pSNPs) were synthesized and provided by M.
Arif Khan in the lab of Dr. Barbara Knutson and Dr. Steve Rankin. Details of pSNP
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synthesis are provided elsewhere (Appendix B). Nonporous silica nanoparticles were
synthesized per methods established by Bogush et al. (1988). Mesoporous silica
nanoparticles (pSNPs) with an average pore size diameter of 2.20 ± 0.16 nm (referred to
as 2.7 nm pSNPs) were synthesized using a modified Stöber method (Kim et al. 2010).
pSNPs with an average pore size diameter of 4.10 ± 0.35 nm (referred to as 4.5 nm
pSNPs) were synthesized per methods established in Gu et al. (2013). pSNPs with an
average pore size diameter of 7.90 ± 2.15 nm (referred to as 8.0 nm pSNPs) were
synthesized using a modified version of methods established by Yamada et al. (2015).
Particle names represent the pore sizes before amine functionalization. After synthesis,
all four types of nanoparticles were amine functionalized by condensing (3Aminopropyl)triethoxysilane (APTES) onto the particle surface, per modified methods
established in Ezzeddine et al. (2015) and Na et al. (2012). Pore size after amine
functionalization for 2.7 nm, 4.5 nm, and 8.0 nm pSNPs was 1.58 ± 0.14 nm, 3.24 ± 0.38
nm, and 7.55 ± 1.92 nm, respectively. Pore size values represent average pore size
estimated by the method of Barrett, Joyner, and Halenda (BJH). The BJH method has
some inherent error that often underestimates pore size by 0.5 nm due to assumptions
(Ravikovitch et al. 2001). Morphology and shape of functionalized and
nonfunctionalized particles were characterized using a Hitachi S-4300 Scanning Electron
Microscope (Hitachi High-Technologies Corporation, Japan). Average pore diameter,
pore size distribution, and surface area were estimated from nitrogen sorption conducted
at 77 K using a Micromeritics TriStar 300 (Micromeritics Instrument Corporation.
Norcross, GA).
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Nanoparticle stock solutions were made up in concentrations of 10 mg/mL stock
solution in nuclease-free H2O. Before being used, pSNP solutions were sonicated using a
Tekmar Sonic Disruptor for 15 seconds (Teledyne Tekmar, Mason, OH) to suspend the
particles in solution. After the initial sonication, all pSNP solutions were vortexed with a
Vortex Genie 2 (Thermo Fisher Scientific, Waltham, MA) for 15 seconds immediately
before being used.
RNase III Digest
To assess the ability of pSNPs to protect dsRNA from digestion by RNase III, 7.2
µg of fluorescently labeled dsRNA was combined with 100 µg of non-FITC labeled,
amine functionalized silica nanoparticles. The treatment groups were as follows: dsRNA
and 8.0 nm pSNPs, dsRNA and 4.5 nm pSNPs, dsRNA and 2.7 nm pSNPs, dsRNA and
nonporous SNPs, dsRNA and RNase III (positive control), and dsRNA only (no RNase,
negative control). Samples were vortexed and shaken on a 55S 12 x 16 Single Platform
Laboratory Shaker (Reliable Scientific, Nesbit, MS) at 40 rpm at room temperature for
one hour to allow for dsRNA attachment. The dsRNA from the negative and positive
control samples were also shaken on a 55S 12 x 16 Single Platform Laboratory Shaker
(Reliable Scientific, Nesbit, MS) for one hour. Three units of ShortCut RNase III (New
England Biolabs- M0245S), 3 µL of 10X ShortCut Reaction Buffer, 3 µL of 10X MnCl2
(200 mM), and nuclease-free H2O to 25 µL were added to each sample. The negative
control sample received nuclease-free H2O to 25 µL. Samples were then vortexed for 15
seconds (Thermo Fisher Scientific, Waltham, MA) and incubated at 37°C for either 15,
30, or 60 minutes. After incubation, 5 µL of 10X EDTA (500 mM) was added to the
solution to inactivate the RNase III. To promote dissociation of the dsRNA from the
nanoparticles, 1 µL of heparin sodium solution (1 µg/µL in nuclease free H2O; Avantor
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Performance Materials, Center Valley, PA) was added to each sample and vortexed. All
solutions except the heparin solution and nuclease-free H2O were provided in the
ShortCut RNase III kit (New England Biolabs, Ipswich, MA).
To assess dsRNA degradation, 5 µL of each sample was run on a 2.0% agarose
gel in 1X sterile TBE buffer. Initially the gel tank was filled with 1X sterile TBE buffer
so that the buffer was touching the gel but not covering it. Samples were loaded into the
dry wells and allowed to run for approximately 5 minutes at 75 volts, after which the gel
was covered with 1X sterile TBE buffer and run at 48 volts for 2.5 hours. Dry loading
the wells was done to prevent sample contamination between wells. Images were taken
on an Alpha Innotech Alpha Imager 2200 Gel Documentation Cabinet &
Transilluminator (Alpha Innotech, San Leandro, CA).
Fluorescence Exchange on Saturated Particles
Another key factor required for an efficient dsRNA delivery vehicle is the ability
to release the dsRNA from particles once the complex enters insect cells. To assess this
capability, we saturated large microparticles with a pore size of 11.8 nm with nonfluorescently labeled IAP84 dsRNA at a concentration of 0.25 mg dsRNA/mg particles.
Excess dsRNA was removed from the solution by pelleting the dsRNA/microparticle
complexes, removing approximately 95% of the solution, and replacing the removed
solution with nuclease free H2O. After washing, an equivalent amount of fluorescently
labeled IAP84 was added to the solution. Fluorescent exchange was monitored after 10
minutes and 40 minutes with a Leica TCS SP5 Confocal Microscope (Leica
Microsystems, Wetzlar, Germany).
Cell Viability Assay
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To establish that in vitro relationships between dsRNA and pSNPs were valid for
cellular analyses, we used fluorescent microscopy and nuclear staining to determine
nuclear structure after several apoptotic-inducing and control treatments. Sf9 cells from
shaker flasks were seeded at a density of 1.0x106 cells (0.45 mL total volume/treatment)
and then exposed to seven different treatment groups: cells only, cells + pSNPs, RING
dsRNA only, RING + pSNPs, EYFP dsRNA only, EYFP + pSNPs, and camptothecin.
The working volume for all samples was 450 µL. In “dsRNA Only” treatments, 3.0 µg
of RING dsRNA (184 bp) or EYFP dsRNA (170 bp) were placed directly into Sf-900 II
serum-free media (GibcoTM Cell Culture). In the “cells + pSNPs” sample, 50 µg of
FITC-labeled 8 nm pSNPs were added to Sf-900 II serum-free media. In “dsRNA +
pSNP” samples, 3.0 µg of the respective dsRNA and 50 µL of pSNP stock solution were
placed in a 0.6 mL microcentrifuge tube together, and then shaken for one hour on a 55S
12 x 16 Single Platform Laboratory Shaker (Reliable Scientific, Nesbit, MS) at 40 rpm at
room temperature for dsRNA attachment to pSNPs. Once dsRNA/pSNP complexes had
formed, cell density was calculated using a Trypan Blue exclusion assay and a
hemocytometer. One million cells were placed in each microcentrifuge tube and Sf-900
II serum-free media was added to make a working volume of 450 µL. The positive
control, the camptothecin sample, was also prepared at that time by combining 50 µL of
100 mM camptothecin with one million cells in a total volume of 450 µL. All samples
were then shaken on a 55S 12 x 16 Single Platform Laboratory Shaker (Reliable
Scientific, Nesbit, MS) at 40 rpm at room temperature for 30 minutes to facilitate cell
uptake of dsRNA/pSNP complexes. After 30 minutes, one drop of NucBlueTM Live
ReadyProbesTM Reagent was added to each sample to stain the nuclei (Thermo Fisher
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Scientific, Waltham, MA). The sample tubes were wrapped in foil and shaken on a 55S
12 x 16 Single Platform Laboratory Shaker (Reliable Scientific, Nesbit, MS) at 40 rpm at
room temperature for 20 additional minutes. After the final shaking, samples were
transferred to a labeled 48 well plate (Corning, Corning, NY) and incubated at 30°C for
12 hours. Samples were imaged on an Olympus IX71 fluorescent microscope (Olympus
Corportation, Tokyo, Japan).

RESULTS AND DISCUSSION
To optimally design nanoparticles for use as a dsRNA delivery system, it is
necessary to understand their physicochemical properties and interactions with dsRNA.
This study investigated two aspects of these interactions in vitro: the binding of dsRNA
to and its mobility on pSMPs and the protection of bound dsRNA from RNase digestion
when bound to pSMPs. An important assumption of this work is that pSMPs are an
appropriate model for pSNP interactions with dsRNA. For RNA silencing to be induced,
dsRNAs must be protected from nuclease digestion long enough to enter insect cells, and
the dsRNA must be released from the particle to induce an RNAi response. Both loading
and release of dsRNA from pSMPs necessarily requires some mobility of the RNA on the
particle. This study investigated the relationship between dsRNA length and pore size in
relation to nuclease degradation, by utilizing fluorescently labeled dsRNA of three sizes
(282 bp, 184 bp, and 82 bp) and four types of silica nanoparticles (nonporous, 2.7 nm, 4.5
nm, and 8.0 nm porous). A prior study (Chapter 2) showed pronounced differences in
mobility of the 282 and 84 bp RNAs in that the larger RNA showed no mobility while the
smaller RNA was highly mobile. In this study, we also test an intermediate size RNA of
184 bp that is an amplimer of a section of the RNA that encodes a functional domain of
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the IAP protein, the RING domain. After identifying a combination of RNA and pore
sizes providing optimal protection of the RNA from nucleases, a fluorescence exchange
experiment showed that dsRNA binding was reversible (Figure 3.4). This dsRNA
exchange experiment saturated the particle with unlabeled dsRNA and then exposed
these ‘loaded’ particles to a solution containing the same concentration of fluorescently
labeled dsRNA. Exchange of the RNA would be indicated by particles which acquired
the fluorescent label and thus dsRNA from the solution. Taken together, the results of
this study begin to delineate features of pSMP and dsRNA interactions that can be
controlled and optimized for both protecting the dsRNA from degradation and enhancing
mobility of the dsRNA on the particle. Finally, this system was tested in insect cells for
its ability to induce apoptosis as indicated by the nuclear condensation, nuclear
fragmentation, and cell membrane changes that occur during apoptosis.
BIR2 Digestion Results
To evaluate the ability of pSNPs to protect dsRNA from nuclease degradation, 7.2
µg of fluorescently labeled BIR2 282 base pair (bp) dsRNA was associated with four
types of pSNPs (nonporous, 2.7 nm, 4.5 nm, and 8 nm porous) and then digested for 15,
30, or 60 minutes. Digestion for 15 minutes was insufficient to completely digest dsRNA
in any treatment (Figure 3.1, lane 6) represented by the presence of diffusing staining.
Diffuse staining is the term used to describe partially degraded RNA, which is 282 bp and
less, but with no sharp, intact band of 282 bp. After digestion for 15 minutes, low
molecular weight, diffuse staining was present for all four types of particles. There was
no evidence that nonporous particles protected this dsRNA from digestion as there was
no high molecular weight staining (~282 bp) at any timepoint. Although all lanes in all
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timepoints exposed to the RNase exhibited low molecular weight, diffuse bands, which is
a result of RNA degradation, there was an increase in the amount of high-molecular
weight staining, which is indicative of protection from RNase digestion, in treatments
with larger pore sizes (4.5 and 8.0 nm) and shorter time points. However, the data
indicates that this length of RNA was susceptible to digestion at all time-points and with
all pSNP treatments, as the intact 282 bp BIR2 dsRNA band is missing in all these
experimental lanes. The high molecular weight staining is indicative of only partial
protection of the RNA from digestion by RNase. This information, summarized in Table
3.2 and Figure 3.1, leads to the conclusion that the BIR2 dsRNA may be too large at 282
bp to enter the pores of nanoparticles and be fully protected from degradation. Full
protection would result in bands of the same size as the negative control (no RNase).
Because of these results, a smaller dsRNA of 184 bp was chosen to repeat the
experiment.
RING Digestion Results
Because the 282 bp dsRNA was not fully protected by any of the nanoparticle
types, we chose to use a shorter dsRNA of 184 bp to repeat the experiment. 7.2 µg of
fluorescently labeled, 184 bp RING dsRNA was combined with 100 µg of non-FITC
labeled silica nanoparticles. The dsRNA/pSNP complexes were then exposed to three
units of RNase III. A 15-minute digestion was not enough to fully digest the RING
dsRNA in any treatment (Fig. 3.2 lane 6). A large portion of the dsRNA was digested
because there is a 20-25 bp band at the bottom of this lane. There was no evidence that
nonporous or 2.7 nm porous particles protected this, or any length of dsRNA, because
there is no high molecular weight (~184 bp) staining present in these samples. All lanes

51

exposed to RNase III exhibited low molecular weight, diffuse bands, which is a result of
RNase degradation. An increase in the amount of high molecular weight staining, which
is representative of intact dsRNA, increased as pore size increased (4.5 and 8.0 nm) and
as digestion time decreased. This data indicates that intermediate dsRNAs, (184 bp) are
less susceptible to degradation than large dsRNAs (282 bp) because there is more high
molecular weight staining present in the intermediate dsRNA samples. This information,
summarized in Table 3.2, in combination with the BIR2 digestion data, lead us to the
conclusion that the intermediate length dsRNA is likely more capable of entering large
pores than larger dsRNA, but that it is still too large to be fully protected. Because this
information showed us that shorter dsRNAs can be better protected by certain pore sizes
but not entirely, we then chose a smaller dsRNA to repeat the experiment.
IAP84 Digestion Results
Because of the results of the BIR2 and RING digestion studies, one would expect
that dsRNAs of smaller lengths would more freely enter pSNPs and thus be better
protected from RNase III digestion than dsRNAs of larger sizes. To investigate this
possibility, 7.2 µg of IAP84 dsRNA (84 bp) was associated with 100 µg of four types of
silica nanoparticles and then progressively digested under increasingly stringent
conditions. After digestion for 15 minutes, partially degraded dsRNA, as indicated by
low molecular weight (less than 82 bp), diffuse staining is present (Fig. 3.3) but this
digestion time was insufficient to completely digest dsRNA in any treatment. There was
no evidence that nonporous or 2.7 nm porous particles protected this dsRNA from
degradation at any time point, as there is no high molecular weight (82 bp) staining
present in these samples. In contrast, high molecular weight staining is present at all time
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points in the 4.5 and 8.0 nm samples. These observations indicate that the 84 bp dsRNA
can enter the 8.0 and 4.5 nm pores and be protected for long periods of time but are still
large too large to enter 2.7 nm pores. In contrast, the 184 bp dsRNA can only be
protected when associated with 8.0 nm pSNPs and the BIR2 dsRNA cannot be protected
under any of the experimental conditions (Table 3.2). This information is valuable for
choosing the best combination of dsRNA and pSNP for dsRNA delivery to cells because
if the chosen length of RNA is too large to enter pores and be protected, the RNA will be
degraded before it enters target cells.
Fluorescence Exchange on Saturated Microparticles Results
Once parameters where dsRNA was protected from nuclease digestion and mobile
as indicated by FRAP analyses, an experiment was performed to evaluate whether
dsRNA molecules could be released from such particles and whether RNAs could be
taken up by these particles from the environment. That is, whether dsRNAs associated
with porous silica microparticles (pSMPs) can be exchanged with unbound dsRNAs in
solution. Release of dsRNAs from nanoparticles may be required to efficiently activate
RNAi responses. To investigate this, pSMP/dsRNA complexes having physicochemical
properties conducive to RNA protection and mobility were assessed and tracked by
fluorescent confocal microscopy. First, pSMPs with 11.8 nm pores were saturated with
non-fluorescently labeled IAP84 dsRNA at a concentration of 0.25 mg dsRNA/mg
pSMPs. Because there is no fluorescent marker on this dsRNA, the confocal microscope
only registers a black image (Fig. 3.4). Then we added an equivalent volume of
fluorescently labeled IAP84 dsRNA to the solution and tracked the presence of the label
on the microparticles. We observed that after only 10 minutes, the fluorescently labeled
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IAP84 dsRNA was loading onto the microparticles (Fig. 3.4, panel A). After 40 minutes,
the fluorescence intensity had increased, indicating that more fluorescent dsRNA
molecules were binding to the microparticles (Fig. 3.4, panel B). This suggests that the
binding of dsRNA to porous particles is fluid, occurs quickly, and that dsRNA binding to
particles is reversible. This observation is important because the dsRNA must be
released into the target environment once it’s been delivered.
Cell Apoptosis Results
As the 8.0 nm pSNPs protected the RING and IAP84 dsRNA better than other
tested pSNPs and better than the larger dsRNAs, an in vivo assay for assessing the ability
of RING/8.0 nm pSNP complexes to cause apoptosis in Sf9 cells was performed.
Importantly, this assay directly tested if this dsRNA/pSNP complex functionally activates
an effective RNAi response. Apoptosis is a characteristic physiological response that
cells experience when the genes regulating apoptosis are knocked down, which results in
nuclear condensation, nuclear fragmentation, and cell debris. Healthy, non-apoptotic
cells contain round, uniform nuclei (Fig. 3.5 panel A). Cells treated with a known
apoptosis inducing drug, camptothecin, contain nuclei that are condensing, fragmenting
and distorted, and cell membranes that are budding (Fig. 3.5 panel C). The first step in
establishing if nanoparticles could efficiently deliver IAP dsRNA without causing
indirect apoptosis was to incubate cells with nanoparticles and observe their nuclei. Cells
treated with only 8 nm pSNPs (Fig. 3.5 panel B) showed round, uniform nuclei, intact
cell membranes, and fluorescently labeled nanoparticles within cell membranes when
observed with a FITC laser. These data indicate that nanoparticles are not contributing to
an apoptotic response.
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After 12 hours, IAP dsRNA/pSNP complexes are still retained by cells but their
nuclei begin to fragment and condense (Fig. 3.5, panel E). Cells only exposed to IAP
dsRNA (panel D) appear to be healthy because their nuclei are generally round and nonfragmented. This indicates that the dsRNA alone is insufficient to cause an apoptosis
response, which is a phenomenon that has been previously recorded by many groups and
is summarized in Terenius et al. (2011).
One important distinction is that the dsRNA delivered to cells by pSNPs is
causing a gene-specific response, instead of a general apoptotic response to any
dsRNA/pSNP complex. For this reason, enhanced yellow fluorescent protein (EYFP)
dsRNA was selected as an exogenous control. When cells are exposed to unbound EYFP
dsRNA, most cells have nuclei that are equivalent to the nuclei in the negative control
(Fig. 3.5, panel F compared to panel A), which is indicative of healthy, non-apoptotic
cells. When cells are exposed to EYFP/pSNP complexes, no apoptotic phenotypes are
observed (panel G). This data is indicative of the apoptotic response not being caused by
the nanoparticles or dsRNA alone, and that the apoptotic phenotype is dsRNA specific.
Although the data needs to be replicated further, this data provides crucial in vivo
verification of the validity of a nanoparticle delivery vehicle.
Protective properties of nanoparticles are influenced by dsRNA length, pore size,
and digestion time. Nonporous nanoparticles exhibited no protection against RNase
digestion at any length after a one hour digestion, but there was evidence of some
protection to RING (184 bp) and BIR2 (282 bp) fragments at the 30-minute and 15minute time points. They provided no protection at any time point to the IAP84 dsRNA

55

(84 bp). Because dsRNA has no way to enter the nanoparticles, the dsRNA molecules
are more exposed to degradation by RNase III.
Nanoparticles having 2.7 nm pores did not completely protect any of the tested
dsRNA fragments after one hour of digestion, but the smaller dsRNA (IAP84) was only
partially degraded in comparison to the larger dsRNAs (RING and BIR2) being
completely digested. These results are consistent with our diffusivity experiments (see
Chapter 2), namely that larger dsRNA molecules are not able to penetrate small pore
sizes and are thus susceptible to degradation. Our earlier experiments also showed that
diffusivity decreased as dsRNA size increased. The inability of the dsRNA to move over
the surface and inside the pSNPs likely makes it more susceptible to degradation because
dsRNA molecules are effectively exposed at their surface binding sites.
For all three dsRNA lengths and time points, the 4.5 nm porous and 8 nm porous
nanoparticles provided the most protection. The 4.5 nm pores are probably large enough
to allow the dsRNA to enter the nanoparticle, but not large enough to allow the RNase III
into the particle. ShortCut RNase III is an enzyme derived from an E. coli that contains
the E. coli RNase III gene (rnc) and the gene coding for the maltose binding protein
(MBP) that weighs 67591 Daltons (Product Datasheet, New England Biolabs, Ipswich,
MA). Although the exact dimensions of the enzyme are unknown, serum albumin is a
globular protein weighing 66400 Da with dimensions (nm) of 7.5 x 6.5 x 4.0 (Erickson,
2009). Because RNase III is a globular protein having a similar weight, it will likely
have similar dimensions to serum albumin, although the exact dimensions for this
product have not been investigated. At a size of 7.5 nm x 6.5 nm x 4.0 nm, the RNase III
would not be able to enter the 4.5 nm pores, thereby protecting dsRNA that is inside the
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particle. Although RNase III may be small enough to enter the 8 nm pores, not all of the
nanoparticles in the 8 nm pSNP sample have pores of exactly 8 nm. When the
nanoparticles are synthesized, their pore sizes vary with a mean pore size of 8 nm. Thus,
a large portion of the dsRNA is protected because many of the nanoparticle pores will be
at 8 nm or smaller.
Our results suggest that both pore size and dsRNA length play critical roles in
protecting dsRNA from digestion by RNase III. Two similar studies recognized the
importance of pore size, but did not address dsRNA length (Na et al. 2012 and Kim et al.
2016). Na et al. (2012) used two pore sizes: 2 nm and 23 nm, and one undisclosed
length of dsRNA for their protection assays. This large disparity in pore sizes makes it
difficult to make any robust conclusions regarding the effect of pore size on dsRNA
protection.
Kim et al. (2016) used a wider range of pore sizes, but the size of the dsRNA in
their experiment was undisclosed. From my work, it is evident that as little as a 98 bp
difference in dsRNA size can make a substantial difference in the degree of protection.
Thus, optimizing dsRNA protection is a function of both pore size and dsRNA length. A
porous nanoparticle will not protect a dsRNA that is too large to properly enter that
nanoparticle’s pores. However, if the pore size is too large, it will not exclude RNase
enzymes, and thus dsRNA inside the particle is not protected. Furthermore, the synthesis
process of porous nanoparticles becomes increasingly difficult as pore size increases (B.
Knutson, personal communication), because it is difficult to fit larger pores onto the same
size nanoparticle surface. If large pores, like the ones used by Na et al. (2012) and Kim
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et al. (2016), are too difficult to create, dsRNA length could also be manipulated to
enhance protection.
For a nanoparticle delivery vehicle to be effective, two things need to occur:
reversible binding of dsRNA and in vivo functionality. By using fluorescent tracking in
mesoporous silica microparticles with equivalent physicochemical properties, we showed
that dsRNA binding is fluid and reversible. With the use of nucleic dye, it was concluded
that apoptosis can be induced in Sf9 cells when IAP dsRNA is delivered by
nanoparticles. It was also established that nanoparticles alone and exogenous
dsRNA/pSNP complexes do not cause apoptosis in insect cells. Although apoptotic work
in insect cells has not been conducted on a pSNP/dsRNA system, knockdown
experiments have been performed in HeLa cells (Na et al. 2012). They found that larger,
23 nm pores can deliver small interfering green fluorescent protein (GFP) RNAs to HeLa
cells and extinguish GFP signals. My research aimed to take in vivo applications beyond
weakening insecticide resistance and diminishing fluorescent proteins, and because of the
images captured on fluorescent microscopy, we now have preliminary findings that
support the efficacy of nanoparticle delivery systems to insect cells.
Three lengths of dsRNA and four nanoparticle types were used to characterize the
protection properties of porous and nonporous silica nanoparticles against nuclease
degradation. I sought to understand how dsRNA length and pore size affected the
digestion of dsRNA when in the presence of RNase III. Although similar experiments
have been conducted, this is the first experiment where dsRNAs length and nanoparticle
pore size were both systematically varied in a factorial design. My results show that
dsRNA molecules 184 bp or less can be protected by either 4.5 nm pSNPs or 8 nm
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pSNPs, but the best protection is provided by 8 nm pSNPs to short dsRNAs. A saturation
experiment with 11.8 nm porous silica microparticles and 84 bp dsRNA revealed that
dsRNA binding to microparticles is fluid, and that dsRNA is highly mobile. When 184
bp IAP dsRNA is combined with 8.0 nm pSNPs, there is an apoptotic response observed
in Sf9 cells exposed to these complexes. The apoptosis phenotype is gene specific.
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Table 3.1. Primers Used for PCR and Subsequent dsRNA Synthesis.
Primer Name
SfIAP_BIR2_F
SfIAP_BIR2_R
SfIAP_RING_F
SfIAP_RING_R
SfIAP_84_R

Primer Sequence (5’3’)
TAATACGACTCACTATAGCTACCTCGGCCGTAGAGATGA
TAATACGACTCACTATAGTGCATATCGTGGGTGCACG
TAATACGACTCACTATAGGTGTTTTTATTGCGATGGTGG
TAATACGACTCACTATAGCCTCACAAGCTTCAGAAAT
TAATACGACTCACTATAGCTCCACTTTACAGAAAGCGC

For each primer, the T7 promoter sequence is at the beginning of the sequence and the
portion in bold is from the Spdoptera frugiperda Inhibitor of Apoptosis (IAP) gene.
SfIAP_BIR2 primers were used to synthesize 282 base pair (bp) segments. SfIAP_RING
primers were used to synthesize 184 bp segment. SfIAP_84_R is used with
SfIAP_BIR2_F to amplify the 84 bp segment IAP84.
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Figure 3.1. Digestion of BIR2 dsRNA in the Presence and Absence of Porous and
Nonporous Silica Nanoparticles.
Results for 15, 30, and 60 minute digestions are shown for BIR2 dsRNA (282 bp).
Samples containing only dsRNA are listed as “RNA Only”. “N.P.” denotes samples with
nonporous nanoparticles. All samples containing RNase III are indicated by a “+”. The
presence of undegraded dsRNA is evident in RNA only in lanes (7, 14, and 21) and
increases as pore size increased and as digestion time decreased. 4.5 nm porous
nanoparticles and 8 nm porous nanoparticles provided some protection at all three time
points (lanes 2, 3, 9, 10, 16, and 17). Partially digested dsRNA, indicated by the presence
of diffuse staining of ~100 bp, was evident with the 2.7 nm porous nanoparticle samples
after 15 min digestion (lane 4).
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Figure 3.2. Digestion of RING dsRNA in the Presence and Absence of Porous and
Nonporous Silica Nanoparticles.
Results for 15, 30, and 60 minute digestions are shown for RING dsRNA (184 bp).
Samples containing only dsRNA are indicated by “RNA Only”. “N.P.” denotes samples
with nonporous nanoparticles. Samples containing RNase III are indicated by a “+”.
Undegraded dsRNA is evident in “RNA Only” control lanes (lanes 7, 14, and 21).
dsRNA protection increased as pore size increased and as digestion time decreased. 4.5
nm porous nanoparticles and 8 nm porous nanoparticles provided protection at all three
time points (lanes 2, 3, 9, 10, 16, and 17). 8 nm porous nanoparticles provided the most
protection of all nanoparticle types (lanes 2, 9, and 16), which is indicated by a dark,
undigested band the same length as the negative controls. Partially digested dsRNA,
indicated by the presence of low molecular weight, diffuse staining of ~75 bp, was
evident with the 2.7 nm porous nanoparticle samples after 15 and 30 minute digestions
(lanes 4 and 11).
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Figure 3.3. Digestion of IAP84 dsRNA in the Presence and Absence of Porous and
Nonporous Silica Nanoparticles.
Results for 15, 30, and 60 minute digestions are shown for IAP84 dsRNA (84 bp).
Samples containing only dsRNA are listed as “RNA Only”. “N.P.” denotes samples with
nonporous nanoparticles. All samples containing RNase III are indicated by a “+”. The
presence of undegraded dsRNA is evident in “RNA Only” lanes (7, 14, and 21) and
increases as pore size increased and as digestion time decreased. 4.5 nm porous
nanoparticles and 8 nm porous nanoparticles provided protection at all three time points
(lanes 2, 3, 9, 10, 16, and 17), which is indicated by the presence of high molecular
weight (84 bp) bands. Partially digested dsRNA, indicated by the presence of low
molecular weight, diffuse staining of ~50 bp, was evident with the 2.7 nm porous
nanoparticle samples after 15 and 30 minute digestions (lanes 4 and 11).
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Table 3.2. Summary of RNase Protection from the Gels Featured Above.
15 Minutes
4.5
2.7
nm
nm
D.S. D.S.

BIR2

8
nm
D.S.

RING

I

D.S.

IAP84

I

I

N.P.

30 Minutes
4.5
2.7
nm
nm
D.S. D.S.

D.S.

8
nm
D.S.

D.S.

D.S.

I

D.S.

D.S.

D.S.

I

I

N.P.

60 Minutes
4.5
2.7
nm
nm
D.S. D.S.

D.S.

8
nm
D.S.

N.P.

D.S.

D.S.

I

D.S.

D.S.

D.S.

D.S.

D.S.

I

I

D.S.

D.S.

D.S.

To summarize the bands present in the gels from above, samples were labeled as either
“I” which stands for intact and signifies a high molecular weight band corresponding to
the length of the undigested control dsRNA, or “D.S.,” which stands for diffuse staining
and represents the presence of low molecular weight, diffuse bands, which is indicative
of degraded dsRNA. No particle types could protect the largest dsRNA, BIR2 (282 bp).
Only the largest pore size, 8 nm, could protect the medium sized dsRNA, RING (184 bp).
The IAP84 dsRNA (84 bp) was protected by the 8 nm and 4.5 nm pSNPs. The digestion
time did not result in different protection results, although the one hour digest could
degrade the positive control.
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Figure 3.4. IAP84 dsRNA Transfer on 11.8 nm Mesoporous Silica Microparticles.
Fluorescence recovery of fluorescently labeled IAP84 dsRNA on 11.8 nm microparticles
saturated with unlabeled IAP84 dsRNA after 10 minutes (left) and 40 minutes (right).
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Figure 3.5. Fluorescent Microscopy Images of Sf9 Cells After Apoptosis Inducing
and Non-Apoptosis Inducing Treatments.
Sf9 cells were exposed to seven treatments: cells only (panel A), cells + 8 nm pSNPs
(panel B), camptothecin (panel C), RING dsRNA only (panel D), RING/8 nm pSNPs
(panel E), EYFP dsRNA only (panel F), and EYFP/8 nm pSNPs (panel G). Pictures in
the first column (A, D, and F) contained no pSNPs while pictures in the second column
(B, E, and G) contained pSNPs. Using the camptothecin treatment as a reference image
for typical apoptosis phenotypes (nuclear fragmentation, nuclear condensation, cell
membrane deformities), and cells only as a healthy phenotype references, it was found
that nanoparticles do not cause apoptosis but are retained by cells. Exogenous dsRNAs,
alone and in combination with nanoparticles, do not cause apoptosis. When a segment of
66

the Inhibitor of Apoptosis gene, RING, dsRNA is delivered to Sf9 cells by nanoparticles,
nuclear condensation and fragmentation is observed, which is indicative of apoptosis.
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Chapter Four: Epilogue and Conclusions
The first step in assessing the viability of nanoparticles as a dsRNA delivery
vehicle is to understand the relationship between dsRNA and porous silica nanoparticles
(pSNPs). This relationship can be characterized with confocal microscopy and
fluorescence recovery after photobleaching (FRAP). Because nanoparticles are too small
to be observed with confocal microscopy, nonporous silica microparticles (SMPs) and
porous silica microparticles (pSMPs) with equivalent chemistries and pore sizes were
used as a model for pSNP-dsRNA interactions. The initial goal was to characterize the
conditions under which dsRNA loading into pSMPs occurred, namely how dsRNA length
and particle pore size influenced dsRNA loading. Because SMPs have no pores, only
surface binding was observed in these samples. Shorter dsRNAs of 84 base pairs (bp)
loaded ubiquitously into all pore sizes, which indicates that this length of dsRNA is small
enough to enter pores as small as 3.6 nm. In contrast, the larger dsRNA (282 bp)
exhibited only surface binding when associated with 3.6 nm pSMPs, which suggests that
this dsRNA is too large to enter smaller pores. 282 bp dsRNA loaded ubiquitously into
the larger 7.4 and 11.8 nm pSMPs, indicating that loading is not simply a function of
correctly orienting the dsRNA molecule to the pore, perhaps indicating that loading may
be constrained by both dsRNA and pore sizes.
Upon discovering that dsRNA loaded into pSMPs in a pore size-dependent
manner and that dsRNA molecules were mobile in pSMPs, further study was conducted
to determine how dsRNA length, pSMP pore size, and dsRNA concentration influenced
the mobility of dsRNA molecules when associated with pSMPs. Fluorescent dsRNA
molecules were associated with four types of microparticles: nonporous, 3.6 nm porous,

68

7.4 nm porous, and 11.8 nm porous. A laser was used to bleach a disk of fluorescent
dsRNA, and then images were captured to track the recovery of fluorescence into the
bleached area. This procedure, referred to as fluorescence recovery after photobleaching
(FRAP), is a tool used to characterize diffusivity, also known as mobility, of dsRNA
molecules. Two optical sections can be observed with this procedure: the surface of the
particle (the “cap” measurement) and the interior of the particle (the “core”
measurement), which helps in determining if different locations in the particle influence
dsRNA mobility. dsRNA mobility was observed on pSMPs in a pore size and dsRNA
length-dependent manner. No mobility was recorded on nonporous SMPs for either
length of dsRNA. The shorter, 84 bp dsRNA was consistently more mobile than the
larger 282 bp dsRNA. Diffusivity of the 84 bp dsRNA was recorded for all pSMP
samples, and was not statistically different at the cap or core of the particle. 282 bp
dsRNA exhibited no mobility in association with 3.6 nm pSMPs, with mobility only
observed in the 7.4 nm and 11.8 nm pSMPs samples. The mobility of the 282 bp dsRNA
was not statistically different on the cap or in the core of the particle when associated
with 7.4 or 11.8 nm samples.
Because diffusivity was only observed in pSMPs and not nonporous SMPs, this
suggests that there is relationship between the dsRNA loaded into the pores and the
movement of dsRNA. To address this hypothesis, three concentrations of 84 bp dsRNA
were associated with 11.8 nm pSMPs, loading was characterized, and then the FRAP
experiment was conducted. At the lowest concentration, 0.07 mg dsRNA/mg pSMPs,
only surface binding was observed and no mobility was recorded. At double that
concentration, 0.13 mg/mg, ubiquitous loading was observed and dsRNAs began
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exhibiting mobility. At four times the original concentration, 0.25 mg/mg, uniform
loading throughout the particle was observed and the dsRNA molecules were highly
mobile. The influence that dsRNA concentration has on loading and mobility indicated
that there are several factors influencing the interactions between dsRNA and pSNPs, and
that these factors should be studied in detail before exposing this system to in vitro and in
vivo assays.
After characterizing the relationship between dsRNA length, pore size, and
dsRNA concentration on pSMP loading and dsRNA mobility, the next step in assessing
the efficacy of pSNPs for delivery of dsRNA to insect cells was to analyze if pSNPs
could protect dsRNA from nucleases. One hypothesis for why RNAi does not work in
lepidopterans is the presence of high numbers of DNA/RNA nucleases in lepidopteran
midgut and hemolymph (and presumably in other insects that show little or no RNAi
response) that degrade delivered dsRNA before it arrives at target cells (Bellés, 2010;
Gatehouse and Price, 2011; Gu and Knipple, 2013; Terenius et al. 2011). Nuclease
activity has been observed in the hemolymph and digestive juices of two species of
model lepidopterans, the tobacco hornworm Manduca sexta and the China silkworm
Bombyx mori (Garbutt et al. 2013 and Liu et al. 2012). Protecting the dsRNA from
nuclease activity may solve one of the problems that may complicate the use of RNAi as
a viable insect control strategy for RNAi-insensitive insects, and porous silica
nanoparticles may be able to provide that protection.
To assess how different types of silica nanoparticles protect dsRNA from RNase
III, which is a double-stranded ribonuclease, four types of nanoparticles (nonporous, 2.7
nm, 4.5 nm, and 8.0 nm porous) and three lengths of fluorescein-12-UTP dsRNA (84 bp,
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184 bp, and 282 bp) were exposed to degradation by RNase III under increasingly
stringent conditions. Protection occurred in a pore size and dsRNA length-dependent
manner. The largest dsRNA, 282 bp, was not protected by any type of nanoparticle,
which indicates that this dsRNA is too large to enter the pores and thus be protected from
degradation. The intermediate dsRNA, 184 bp, exhibited some protection from RNase
III when it was associated with 8.0 nm pSNPs, but not when it was associated with other
types of nanoparticles. The smallest dsRNA, 84 bp, was well protected by both the 8.0
and 4.5 nm pSNPs. These data indicate that the larger dsRNA molecules traditionally
used to induce an RNAi response may be too large to be protected by pSNPs, and that a
smaller dsRNA associated with a large pore size may be more suitable for overcoming
this obstacle.
Another key factor in whether pSNPs can be used to effectively deliver dsRNA to
insect cells is determining if dsRNA binding to pSNPs is reversible. This is important
because dsRNA molecules will need to become unbound from the pSNP once inside the
insect cell. If this binding reversal doesn’t occur, then the system is not appropriate for
this application. To address this question, non-fluorescently labeled 84 bp dsRNA was
associated with 11.8 nm pSMPs (pSMPs were used in place of pSNPs for visualization
with confocal microscopy) at a concentration of 0.25 mg/mg. Then, an equivalent
amount of fluorescein-12-UTP dsRNA was added to solution and the presence of
fluorescence on the pSMPs was tracked with confocal microscopy. Because the initial
dsRNA used was unlabeled, only a black image was registered by the microscope. As
fluorescent dsRNA binds to the particles, the fluorescent signal increases as the number
of fluorescently labeled dsRNA molecules bound to the surface of the particles increases.
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This increase in fluorescence was observed after only 10 minutes, and continued to
increase after 40 minutes. These data indicate that dsRNA binding to particles is
reversible and occurs quickly.
The final test performed was to combine all of the collected information and
expose Spodoptera frugiperda cells to dsRNA/pSNP complexes. Because the
intermediate length of dsRNA, 184 bp, had equivalent protection from RNase III in the
8.0 nm pSNPs as the shorter 84 bp dsRNA and is closer to the length typically used to
initiate an RNAi response, the intermediate dsRNA and 8.0 nm pSNPs were used in the
cell viability assay. Sf9 cells were exposed to seven treatments: cells only (negative
control for dsRNA only samples), cells + pSNPs (negative control for dsRNA + pSNP
samples), camptothecin (positive control for all treatments), RING IAP dsRNA
(apoptosis treatment), RING dsRNA + pSNPs, EYFP dsRNA (exogenous control), and
EYFP dsRNA + pSNPs. Apoptotic phenotypes were recorded by staining the nuclei with
a Hoescht nuclear dye, and then the nuclei were observed with fluorescence microscopy.
Cells in apoptosis exhibit nuclear condensation, nuclear fragmentation, and changes in
cell membrane morphology that are easy to observe under a microscope, which makes
this assay valuable for quickly observing changes occurring in samples. Using this
system, it was determined that pSNPs only and dsRNA only do not cause apoptosis under
the tested experimental conditions. Apoptosis was only observed when the RING
dsRNA was delivered on pSNPs, with apoptotic phenotypes beginning to appear after six
hours, which strongly indicates that the pSNPs facilitate the delivery of IAP dsRNA to
cells and induction of apoptosis in these cells. As time increased, the level of apoptosis
increased until it was approximately 60% in the RING dsRNA + pSNP sample after 24

72

hours. Some apoptosis was observed in the EYFP + pSNP sample, which may indicate
that cells become apoptotic in the presence of any dsRNA associated with pSNPs, but
there was a significant delay relative to cells receiving the IAP dsRNAs. Although that
conclusion is interesting, the marked difference in levels of apoptosis between the EYFP
dsRNA + pSNP sample and the RING dsRNA + pSNP sample indicate that the
phenotype is strongly gene dependent. These preliminary data, in combination with the
mobility and protection data, indicate that porous silica nanoparticles may be a viable
strategy for inducing RNAi in RNAi insensitive insect species.
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Appendix A: Synthesis of Microparticles, Written by Shanshan Zhou
Synthesis of Santa Barbara Amorphous Batch Mesoporous Silica Particles
Spherical Santa Barbara Amorphous Batch (SBAS) materials were prepared using
Schlipf’s synthesis procedure1. Initially, 0.465 g of Cetyltrimethylammonium bromide
(CTAB) dissolved in 20 mL of deionized water was added to 3.10 g poly (ethylene
glycol)-block-poly (propylene glycol)-block-poly (ethylene glycol) (P123). This solution
was placed in a water bath at 30°C and stirred vigorously while 7.8 mL of 200 proof
ethanol and 45.9 mL of 1.5 M HCl were added. After the P123 was completely
dissolved, 10 mL of tetraethoxysilane (TEOS) was slowly added drop wise. This
solution was mixed for 2 h. At the end of 2 h, the solution was poured into a Parr 4748
Teflon lined bomb, which had been acclimated to the hydrothermal aging temperature,
between 60°C and 120°C, prior to use. The sample was kept at the desired hydrothermal
aging temperature in an oven for 3 days. At the end of the 3-day period, the sample was
removed from the bomb and mixed in a high-speed mixer to homogenize the solution.
After homogenization, the sample was filtered and rinsed with deionized water. After
filtration, the sample was placed into a single walled Whatman cellulose extraction
thimble, and the surfactants were removed using Soxhlet extraction with 200 mL of 200
proof ethanol over 24 h. The pore dimension (5-12 nm) increased as the hydrothermal
aging (60-120°C) temperature increased.
Nitrogen Adsorption
Average pore diameter, pore size distribution and surface area were estimated
from nitrogen sorption conducted at 77 K using Micromeritics TriStar 300. Samples
were degassed at 120ºC for a minimum of 4 h under flowing dry N2 gas before the
nitrogen sorption experiment. The specific surface area was estimated using the
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Brunauer, Emmett and Teller (BET) isotherm, and average pore diameter and pore size
distribution were estimated by the method of Barrett, Joyner and Halenda (BJH) for
adsorption branch.
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Table A.1. Characterization Results for Non-Amine Functionalized and Amine
Functionalized Microparticles.

Nonporous

BET
surface
area
(m2/g)
0.54a

Total
pore
volume
(cm3/g)
-

Average
pore
diameter
(nm)b
-

External
surface
area
(m2/g)c
-

Nonporous-A

0.54

-

-

Particle type

SBAS-3.6
SBASA-3.6
SBAS-7.4
SBASA-7.4
SBAS-11.8
SBASA-11.8

551
191
668
400
367
319

0.81
0.52
1.27
0.93
1.82
1.60

Micropore
volume
(cm3/g)c

Mesopore
volume
(cm3/g)c

-

-

-

-

-

3.6 ± 1.4

702

0.028

3.0 ± 0.9

270

0.023

7.4 ± 1.1

849

0.033

7.2 ± 1.2

548

0.030

11.8 ± 2.6

451

0.011

11.3 ± 3.0

441

0.034

0.68
0.42
1.14
0.86
1.73
1.56

a

Surface area determined by considering all particles as 5 µm diameter spheres;bThe average and range
were determined from the peak and full width at half maximum (FWHM) of the BJH pore distribution,
respectively, cFrom αs plot analysis

BET surface area (m2/g), total pore volume as a function of pore diameter (cm3/g),
average pore diameter (nm), and external surface area (m2/g), and micro- and mesopore
volume (cm3/g) on bare silica microparticles (SBAS) and silica microparticles following
amine functionalization (SBASA).
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Appendix B: Synthesis of Nanoparticles, Written by M. Arif Khan
Materials & Methods
Nonporous Stöber Particles (SNP) Synthesis
SNPs were synthesized according to the method reported by Bogush et al.
(1988).1 10 mL of deionized ultra-filtered (DIUF) water (3 M in ethanol) and 6.75 mL of
28.5% NH4OH (0.5 M in ethanol) were added to 183.25 mL of ethanol. The solution was
stirred for 5 min. Then, 7.6 mL of tertraethyl orthosilicate (TEOS) (0.17 M in ethanol)
was added rapidly and the solution was stirred for 24 hours at room temperature. The
particles were separated from the solution using high speed centrifugation (17,000 rpm)
followed by washing with DIUF water and ethanol 3 times. Finally, separated particles
were dried in an oven at 84ºC overnight.
Mesoporous Silica Nanoparticle with Small Average Pore Diameter (pSNP-s)
Synthesis
Ordered mesoporous silica nanoparticles were synthesized by a modified Stöber
method based on the report of Kim et al. (2010),2 where cetyltetramethylammonium
bromide (CTAB) was used as a structure directing compound and TEOS and the tri-block
copolymer Pluronic F127 were used as the silica source and dispersing agent,
respectively. Initially 0.5 g of CTAB and 2.05 g of F127 were dissolved in 96 mL of
DIUF water, followed by the addition of 43.1 mL of ethanol and 11.9 mL of NH4OH
solution (29.3 wt%) and the solution was stirred until complete dissolution of solutes.
Then, 1.9 mL of TEOS was added to the solution and stirred vigorously for exactly 1 min
at room temperature. After that, the solution was aged for 24 h without any stirring at
room temperature for complete silica condensation. The particles were removed from the
solution by ultrahigh speed centrifugation (Beckman-Coulter) at 17,000 rpm and were
washed 3 times with DIUF water and ethanol with repeated centrifugation and dried at
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80ºC in air overnight. Finally, template free silica particles were obtained by washing in
200 mL acidic ethanol (HCl 1.5 M) for 24 hours (acidic ethanol wash) followed by
repeated centrifugation and washing with DIUF water and ethanol. Template free
particles were dried overnight at 84ºC.
Mesoporous Silica Nanoparticle with Medium Average Pore Diameter
(pSNP-m) Synthesis
Synthesis of medium pore pSNPs was achieved by following the method reported
by Gu et al. (2013).3 First, 0.4 mL of N,N-dimethylhexadecylamine (DMHA) and 0.1 g
of Pluronic F127 were mixed with 1.02 g of octadecyltrimethylammonium bromide
(OTAB) and 364 mL of water was added. 3.5 mL of 2 M NaOH solution was then added
under stirring. The solution temperature was raised to 80ºC, and kept stirring under
constant temperature until a clear homogeneous solution was obtained. Then, 5.0 mL of
TEOS was added dropwise. The solution was stirred at 80ºC for 2 h and cooled to room
temperature afterwards. The particles were separated by centrifugation and repeated
washing with water and ethanol. Template-free particles were achieved by the acidic
ethanol wash described previously.
Mesoporous Silica Nanoparticle with Large Average Pore Diameter (pSNP-l)
Synthesis
Large pore pSNPs were synthesized using a modified method described by
Yamada et al. (2015)4 where 1,3,5-triisopropylbenzene (TIPB) was used as a CTAB pore
expanding agent. Initially, 0.56 mL of triethanol-amine (TEA) and 3.0 g of CTAB were
added to 360 mL of DIUF water. The solution was kept stirring at 80ºC for 2 h for
complete mixing and emulsion formation and 15.96 mL of TIPB was added under
vigorous mixing. After 30 min, complete colloidal state (oil-in-water) was obtained and
4.77 mL of tetrapropyl orthosilicate (TPOS) was added with constant stirring. Then, the
78

solution was stirred vigorously for 12 h to obtain white solid particles. The particles were
then separated by repeated centrifugation and washing and the surfactant was removed by
acidic ethanol washing.
Amine Functionalization and Fluorescent Group Attachment
Amine Functionalization
Amine functionalized SNPs and pSNPs were obtained by condensing (3Aminopropyl)triethoxysilane (APTES) on the particle surface using a modified version of
the methods reported in the literature.5, 6 200 mg of the particles (either SNPs or pSNPs)
were sonicated in 25 mL of dry ethanol for 15 min and a uniformly dispersed solution
was obtained. 0.5 mL of APTES was added drop wise under constant stirring and the
solution was kept stirring overnight in a closed environment at room temperature.
Particles were centrifuged at 17,000 rpm followed by repeated washing with dry ethanol
and cured at 84ºC overnight. After curing, particles were stirred in excess ethanol for 24
hours to remove any remaining, loosely bound amine groups. The functionalized
particles were again washed 3 times with dry ethanol and dried in an oven at 84ºC.
Amine functionalized nonporous and porous particles were denoted as SNPA and
pSNPA, respectively.
Fluorescent (RITC) Tagging
Amine functionalized particles were suspended in 25 mL of dry ethanol after
sonication for 15 min and 3.2 mg of rhodamine B isothiocyanate (RITC) was added to the
uniformly dispersed solution. After 24 hours of stirring, the bright red labelled particles
were washed and centrifuged in ethanol repeatedly until the supernatant became
completely clear and then dried in an oven. The dry particles were then washed in water
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and ethanol for 24 hours each to remove excess dyes and again dried in the oven
overnight.
Materials Characterization
The morphology and shape of bare and functionalized particles were
characterized using a Hitachi S-4300 Scanning Electron Microscope (SEM) (Hitachi
High-Technologies Corporation, Japan). The samples for SEM characterization were
prepared by dispersing the particles onto a double-sided carbon tap attached on a 15-mm
aluminum mount. Samples were put in a desiccator for 24 hours after excess silica
materials were blown off with dry nitrogen gas. Prior to analysis, the samples were
coated with gold-palladium alloy using an Emscope SC400 (Quorum Technologies,
Lewes, United Kingdom) with a gold-palladium alloy sputtering. Average and standard
deviation of particle diameters were calculated by considering 20 random particles
throughout the SEM image using ImageJ Software (National Institutes of Health,
Bethesda, MD). Transmission electron microscopy (TEM), high resolution (HR) TEM
and scanning-transmission electron microscopy (STEM) imaging were performed using a
JEOL 2010F TEM (Jeol USA Inc., Peabody, MA) at a voltage of 200 kV. Samples were
prepared 3 days in advance by sonicating approximately 5 mg of particles in 2 mL of
ethanol for 15 min. Then a Lacey carbon 300 mesh copper grid (Ted Pella Inc., 01895-F)
was dipped into the particle solution for 2-3 seconds and left in a desiccator before
analysis. Average pore diameter, pore size distribution and surface area were estimated
from nitrogen sorption conducted at 77 K using Micromeritics TriStar 3000
(Micromeritics Instrument Corporation, Norcross, GA). Samples were degassed at 135ºC
for a minimum of 4 h under flowing dry N2 gas before the nitrogen sorption experiment
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was conducted. The specific surface area was estimated using the Brunauer, Emmett and
Teller (BET) isotherm, and average pore diameter and pore size distribution were
estimated by the method of Barrett, Joyner and Halenda (BJH) for adsorption branch.
Micropore volume and external surface area were estimated using the method described
in Jaroniec et al.7 To confirm the successful removal of surfactant from SNP pores,
Fourier transform infra-red (FTIR) spectroscopy was conducted using Thermo Nicolet
Nexus 470 with a Deuterated triglycine sulfate (DTGS) detector before and after acidic
ethanol wash (Thermo Fisher Scientific, Waltham, MA). For the analysis, 0.5 g of
anhydrous KBr was mixed was the particles (0.5-1.0 wt %) and the mixture was crushed
using a mortar and pestle. A small amount of the sample was put into the FTIR pellet
dye to press until samples became translucent, rigid, and solid. The pellet was then put in
the FTIR pellet holder in the sample chamber under a constant flow of dry nitrogen and
infra-red radiation was allowed to pass through it. The FTIR spectra were recorded using
Thermo OMNIC software (Thermo Fisher Scientific, Waltham, MA). Low angle x-ray
diffraction (XRD) analysis was performed using a Bruker-AXS D8 Discover
diffractometer (Bruker, Billerica, MA) using an x-ray wavelength of 1.54 Å to determine
the degree of mesostructural ordering. Nanoparticles were scanned at 0.5°/min in 2θ
increments of 0.02º from 1.5 to 6º. Samples were prepared in a powder sample holder
and tapped flat with a spatula. Data analysis was performed with the Bruker DiffracSuite software (Bruker, Billerica, MA).
Amine Quantification
The amount of amine group on the particle surface was determined by a modified
version of the previously reported method,8 where primary amine groups in aminosilane
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following dissolution in alkaline solution, reacts with fluorescamine to produce
fluorescent pyrrolinone.9 30 mg of functionalized particles were dissolved over an 8 h
period in 30 mL of 0.02 M NaOH solution at room temperature under vigorous stirring.
100 μL of this solution and 1.0 mL of 1.0 mM fluorescamine in acetone solution were
mixed with 2.0 mL of PBS solution at pH 7.4. Maximum fluorescent intensity of this
solution was measured at an emission wavelength of 480 nm after excitation at 366 nm
using a Varian Cary Eclipse fluorescent spectrophotometer (Agilent Technologies, Santa
Clara, CA), with both excitation and emission slits held at 5 nm. Calibration curve was
prepared using the same procedure by dissolving known amounts of APTES and 30 mg
of non-functionalized pSNPs.
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Characterization Results

(a)

(b)

(c)

(d)

Figure B.1. SEM Images of (a) SNP, (b) pSNP-s, (c) pSNP-m and (d) pSNP-l.
SEM images for all four particle types that contain scale bars of 500 nm.
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TEM of SNPs

TEM of pSNP-s

TEM of pSNP-m

Figure B.2. TEM Images of Nonporous and Porous Silica Nanoparticles.
TEM images for 3 particle types: SNPs with a scale bar of 0.1 µm, pSNP-s with a scale
bar of 20 nm, and pSNP-m with a scale bar of 20 nm. TEM images were not taken for
pSNP-l.
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Table B.1. Surface Properties Characterization Results from Nitrogen Adsorption
Experiments Before and After Amine Functionalization.
Particle
type

SNP
SNPA
pSNP-s
pSNPA-s
pSNP-m
pSNPA-m
pSNP-l
pSNPA-l

BET
surface
area
(m2/g)
14.4a
14.4
953
585
862
366
729
469

Total
pore
volume
(cm3/g)
1.21
0.57
1.37
0.66
2.32
1.50

Average
pore
diameter
(nm)b
2.20±0.16
1.58±0.14
4.10±0.35
3.24±0.38
7.90±2.15
7.55±1.92

External
surface
area
(m2/g)c
135.6
78.9
223.5
159.9
618.6
369.3

Micropore
volume
(cm3/g)c

Mesopore
volume
(cm3/g)c

0
0
0.006
0
0.017
0

0.818
0.278
0.923
0.255
0.823
0.510

a

Surface area determined by considering all particles as 190 nm diameter spheres, bThe average and range
were determined from the peak and full width at half maximum (FWHM) of the BJH pore distribution,
respectively, cFrom αs plot analysis

Measurements taken for surface property characterization include BET surface area (in
m2/g), total BJH pore volume (in cm3/g), average pore diameter (in nm), external particle
surface area (in m2/g), and the volume for micro- and mesopores (cm3/g).
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Table B.2. Monolayer Coverage of Amine Groups on Silica Surfaces8.

14.4a
30.11
28.6
0.129
27.8

2.7 nm
porous
953
840.3
798.3
3.61
443.9

4.5 nm
porous
862
491.4
466.8
2.11
318.3

8.0 nm
porous
725
356.9
339.1
1.53
253.2

0.125

2.00

1.44

1.14

0.00897

0.00378

0.00245

0.00211

272

114

74

64

-

585

366

469

-

1.21

1.37

2.32

-

0.57

0.66

1.50

Nonporous
Surface area (m2/g)
µl APTES/g SiO2
mg APTES/g SiO2
mmol APTES/g SiO2
mg APTES/g particles
mmol APTES/g
particles
mmol APTES/m2
surface
% of monolayer
coverage
Surface area after
functionalization (m2/g)
Pore volume before
functionalization
(cm3/g)
Pore volume after
functionalization
(cm3/g)
a

Surface area determined by considering all particles as 190 nm diameter spheres

Measurements taken for BET specific surface area, amount of amine grafted and % of
monolayer surface coverage by amine group for amine functionalized nonporous and
porous nanoparticles.
50 Å2/amino-silane
= 2.0 -NH2 containing molecule/nm2
= 0.0033 mmol APTES/m2 surface
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